"Term","Jaccard","Odds_Ratio","Fold_Enrichment","PValue","FDR","Genes"
"GO:0016639~oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor",0.0303030303030303,Inf,598.333333333333,0.00167130919220071,0.0399794751502749,"2746"
"GO:0004423~iduronate-2-sulfatase activity",0.0303030303030303,Inf,598.333333333333,0.00167130919220071,0.0399794751502749,"3423"
"R-HSA-2206296~MPS II - Hunter syndrome",0.0303030303030303,Inf,598.333333333333,0.00167130919220071,0.0399794751502749,"3423"
"GO:0097473~retinal rod cell apoptotic process",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"208"
"GO:0006422~aspartyl-tRNA aminoacylation",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"1615"
"GO:0004815~aspartate-tRNA ligase activity",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"1615"
"GO:0004352~glutamate dehydrogenase (NAD+) activity",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"2746"
"GO:0004353~glutamate dehydrogenase [NAD(P)+] activity",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"2746"
"GO:0004354~glutamate dehydrogenase (NADP+) activity",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"2746"
"R-HSA-109703~PKB-mediated events",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"208"
"R-HSA-165160~PDE3B signalling",0.0294117647058824,602.985872029039,299.166666666667,0.0033399096174771,0.0532627691629243,"208"
"GO:0071486~cellular response to high light intensity",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"208"
"GO:0032484~Ral protein signal transduction",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"57148"
"GO:1903676~positive regulation of cap-dependent translational initiation",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"208"
"GO:0005483~soluble NSF attachment protein activity",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"8774"
"GO:0033149~FFAT motif binding",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"9218"
"R-HSA-165181~Inhibition of TSC complex formation by PKB",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"208"
"R-HSA-5339700~Signaling by TCF7L2 mutants",0.0285714285714286,307.229522005107,199.444444444444,0.00500580552907215,0.0623325647387203,"1488"
"GO:0010748~negative regulation of long-chain fatty acid import across plasma membrane",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"208"
"GO:0006538~glutamate catabolic process",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"2746"
"GO:0030209~dermatan sulfate proteoglycan catabolic process",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"3423"
"GO:0006537~glutamate biosynthetic process",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"2746"
"GO:0050922~negative regulation of chemotaxis",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"1845"
"R-HSA-211163~AKT-mediated inactivation of FOXO1A",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"208"
"R-HSA-165158~Activation of AKT2",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"208"
"WP5441:Artemisinin inhibition of uveal melanoma",0.0277777777777778,203.247058239348,149.583333333333,0.00666900117376557,0.0704897914761965,"208"
"GO:1990264~peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"1845"
"GO:0048386~positive regulation of retinoic acid receptor signaling pathway",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"1488"
"GO:0090114~COPII-coated vesicle budding",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"9218"
"GO:0034766~negative regulation of monoatomic ion transmembrane transport",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"10971"
"GO:0072350~tricarboxylic acid metabolic process",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"2746"
"R-HSA-5368598~Negative regulation of TCF-dependent signaling by DVL-interacting proteins",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"1857"
"WP5507:Mitochondrial carrier deficiency associated with shuttle disturbances",0.027027027027027,152.884665581027,119.666666666667,0.00832950079188322,0.0772603695900188,"2746"
"GO:0043462~regulation of ATP-dependent activity",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"203547"
"GO:0061817~endoplasmic reticulum-plasma membrane tethering",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"9218"
"GO:0120183~positive regulation of focal adhesion disassembly",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"1845"
"GO:0034982~mitochondrial protein processing",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"10730"
"GO:0033549~MAP kinase phosphatase activity",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"1845"
"GO:0004046~aminoacylase activity",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"1615"
"R-HSA-9755779~SARS-CoV-2 targets host intracellular signalling and regulatory pathways",0.0465116279069767,126.483397935401,99.7222222222222,0.00017691675801095,0.0292298017183013,"10971, 208"
"R-HSA-9614399~Regulation of localization of FOXO transcription factors",0.0465116279069767,126.483397935401,99.7222222222222,0.00017691675801095,0.0292298017183013,"10971, 208"
"WP4661:Amino acid metabolism pathway excerpt histidine catabolism extension",0.0263157894736842,122.575368633034,99.7222222222222,0.00998730861730746,0.0825314866648407,"2746"
"GO:0090370~negative regulation of cholesterol efflux",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"6721"
"GO:0010886~positive regulation of cholesterol storage",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"6721"
"GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"203547"
"GO:0010636~positive regulation of mitochondrial fusion",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"10730"
"GO:0070728~L-leucine binding",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"2746"
"GO:0004176~ATP-dependent peptidase activity",0.0256410256410256,102.125825462209,85.4761904761905,0.0116424288774843,0.0882373726706501,"10730"
"R-HSA-111447~Activation of BAD and translocation to mitochondria ",0.0434782608695652,97.3186892372413,79.7777777777778,0.000280576429248304,0.0292298017183013,"10971, 208"
"GO:0070972~protein localization to endoplasmic reticulum",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"9218"
"GO:0071499~cellular response to laminar fluid shear stress",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"6721"
"GO:0150012~positive regulation of neuron projection arborization",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"1857"
"GO:0006027~glycosaminoglycan catabolic process",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"3423"
"GO:0034046~poly(G) binding",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"9987"
"R-HSA-8941332~RUNX2 regulates genes involved in cell migration",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"208"
"KW-0320~Glycogen biosynthesis",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"208"
"WP3634:Insulin signaling in adipocytes normal condition ",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"208"
"WP3635:Insulin signaling in adipocytes diabetic condition ",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"208"
"WP1559:Transcription factors regulate miRNAs related to cardiac hypertrophy",0.025,87.7354859563576,74.7916666666667,0.0132948657934353,0.0901868134793485,"208"
"GO:0034214~protein hexamerization",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"10730"
"GO:0010907~positive regulation of glucose metabolic process",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"208"
"GO:0032933~SREBP signaling pathway",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"6721"
"GO:0032287~peripheral nervous system myelin maintenance",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"208"
"R-HSA-9840373~Cellular response to mitochondrial stress",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"10730"
"R-HSA-201688~WNT mediated activation of DVL",0.024390243902439,76.8073157991691,66.4814814814815,0.0149446235797661,0.0943379363472736,"1857"
"GO:0097094~craniofacial suture morphogenesis",0.0238095238095238,68.1336700756182,59.8333333333333,0.0165917064446771,0.0985742559360228,"1112"
"GO:0051451~myoblast migration",0.0238095238095238,68.1336700756182,59.8333333333333,0.0165917064446771,0.0985742559360228,"10276"
"GO:0030200~heparan sulfate proteoglycan catabolic process",0.0238095238095238,68.1336700756182,59.8333333333333,0.0165917064446771,0.0985742559360228,"3423"
"GO:0044829~positive regulation by host of viral genome replication",0.0238095238095238,68.1336700756182,59.8333333333333,0.0165917064446771,0.0985742559360228,"9218"
"R-HSA-198693~AKT phosphorylates targets in the nucleus",0.0238095238095238,68.1336700756182,59.8333333333333,0.0165917064446771,0.0985742559360228,"208"
"GO:2000035~regulation of stem cell division",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"10730"
"GO:0035694~mitochondrial protein catabolic process",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"10730"
"GO:0044828~negative regulation by host of viral genome replication",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"9218"
"GO:0035627~ceramide transport",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"9218"
"GO:0032000~positive regulation of fatty acid beta-oxidation",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"208"
"GO:0006686~sphingomyelin biosynthetic process",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"9218"
"R-HSA-2206281~Mucopolysaccharidoses",0.0232558139534884,61.406308678614,54.3939393939394,0.0182361185899678,0.100464435141095,"3423"
"GO:0000027~ribosomal large subunit assembly",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"6152"
"GO:1903898~negative regulation of PERK-mediated unfolded protein response",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"208"
"R-HSA-4641265~Repression of WNT target genes",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"1488"
"R-HSA-9673324~WNT5:FZD7-mediated leishmania damping",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"1857"
"R-HSA-9664420~Killing mechanisms",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"1857"
"WP106:Alanine and aspartate metabolism",0.0227272727272727,55.8478372184057,49.8611111111111,0.0198778642110552,0.105052200975867,"1615"
"GO:0060644~mammary gland epithelial cell differentiation",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"208"
"GO:0019079~viral genome replication",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"1488"
"GO:0005520~insulin-like growth factor binding",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"51232"
"R-HSA-1358803~Downregulation of ERBB2:ERBB3 signaling",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"208"
"R-HSA-202670~ERKs are inactivated",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"1845"
"R-HSA-75035~Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex",0.0222222222222222,51.1257663307447,46.025641025641,0.0215169474969737,0.109267627233235,"10971"
"GO:1901524~regulation of mitophagy",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"6721"
"GO:0031113~regulation of microtubule polymerization",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"57606"
"R-HSA-198323~AKT phosphorylates targets in the cytosol",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"208"
"R-HSA-2024101~CS/DS degradation",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"3423"
"R-HSA-6804759~Regulation of TP53 Activity through Association with Co-factors",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"208"
"R-HSA-8964539~Glutamate and glutamine metabolism",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"2746"
"KW-0313~Glucose metabolism",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"208"
"WP5318:Female steroid hormones in cardiomyocyte energy metabolism",0.0217391304347826,47.2067800934516,42.7380952380952,0.0231533726303919,0.111356696936647,"208"
"GO:0010458~exit from mitosis",0.0212765957446809,43.8867856427874,39.8888888888889,0.0247871437876156,0.115546224117654,"6152"
"GO:0015918~sterol transport",0.0212765957446809,43.8867856427874,39.8888888888889,0.0247871437876156,0.115546224117654,"9218"
"R-HSA-114452~Activation of BH3-only proteins",0.0327868852459016,45.2329113734493,39.8888888888889,0.001144303282495,0.0371489887067126,"10971, 208"
"WP3873:RIOK1 and RIOK2 in EGFR and PI3K mediated tumorigenesis",0.0212765957446809,43.8867856427874,39.8888888888889,0.0247871437876156,0.115546224117654,"208"
"GO:0045542~positive regulation of cholesterol biosynthetic process",0.0208333333333333,40.9321278645644,37.3958333333333,0.0264182651386046,0.117716681426429,"6721"
"GO:0006892~post-Golgi vesicle-mediated transport",0.0208333333333333,40.9321278645644,37.3958333333333,0.0264182651386046,0.117716681426429,"9522"
"R-HSA-8949664~Processing of SMDT1",0.0208333333333333,40.9321278645644,37.3958333333333,0.0264182651386046,0.117716681426429,"10730"
"R-HSA-9735871~SARS-CoV-1 targets host intracellular signalling and regulatory pathways",0.0208333333333333,40.9321278645644,37.3958333333333,0.0264182651386046,0.117716681426429,"10971"
"WP2011:SREBF and miR33 in cholesterol and lipid homeostasis",0.0208333333333333,40.9321278645644,37.3958333333333,0.0264182651386046,0.117716681426429,"6721"
"R-HSA-9861718~Regulation of pyruvate metabolism",0.03125,40.8498511577221,36.2626262626263,0.00138460203716553,0.0397610503897186,"54994, 64795"
"GO:0032897~negative regulation of viral transcription",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"81603"
"GO:0061025~membrane fusion",0.0307692307692308,39.6337246268844,35.1960784313725,0.00146960417324602,0.0397610503897186,"8774, 9218"
"GO:0071404~cellular response to low-density lipoprotein particle stimulus",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"6721"
"GO:0045725~positive regulation of glycogen biosynthetic process",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"208"
"GO:0031571~mitotic G1 DNA damage checkpoint signaling",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"51322"
"GO:0021554~optic nerve development",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"6152"
"GO:0036002~pre-mRNA binding",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"55082"
"GO:0031435~mitogen-activated protein kinase kinase kinase binding",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"81603"
"GO:0070403~NAD+ binding",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"2746"
"WP5372:Involvement of secretase in neurodegenerative diseases",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"208"
"WP4815:Glycosaminoglycan degradation",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"3423"
"hsa00910_Nitrogen_metabolism",0.0204081632653061,38.4123038861584,35.1960784313725,0.0280467408469746,0.117730763400105,"2746"
"GO:0044790~suppression of viral release by host",0.02,36.145294047421,33.2407407407407,0.0296725750700105,0.120412369368927,"81603"
"GO:0050872~white fat cell differentiation",0.02,36.145294047421,33.2407407407407,0.0296725750700105,0.120412369368927,"1488"
"GO:0008593~regulation of Notch signaling pathway",0.02,36.145294047421,33.2407407407407,0.0296725750700105,0.120412369368927,"6721"
"GO:0019076~viral release from host cell",0.02,36.145294047421,33.2407407407407,0.0296725750700105,0.120412369368927,"9218"
"WP5101:Congenital generalized lipodystrophy",0.02,36.145294047421,33.2407407407407,0.0296725750700105,0.120412369368927,"208"
"GO:0050868~negative regulation of T cell activation",0.0196078431372549,34.1336557929939,31.4912280701754,0.0312957719586755,0.122620072027742,"1845"
"GO:0005978~glycogen biosynthetic process",0.0196078431372549,34.1336557929939,31.4912280701754,0.0312957719586755,0.122620072027742,"208"
"GO:0006515~protein quality control for misfolded or incompletely synthesized proteins",0.0196078431372549,34.1336557929939,31.4912280701754,0.0312957719586755,0.122620072027742,"10730"
"hsa00531_Glycosaminoglycan_degradation",0.0196078431372549,34.1336557929939,31.4912280701754,0.0312957719586755,0.122620072027742,"3423"
"GO:0006541~glutamine metabolic process",0.0192307692307692,32.3686908327399,29.9166666666667,0.0329163356576186,0.12571827358309,"2746"
"GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway",0.0192307692307692,32.3686908327399,29.9166666666667,0.0329163356576186,0.12571827358309,"1845"
"R-HSA-210745~Regulation of gene expression in beta cells",0.0192307692307692,32.3686908327399,29.9166666666667,0.0329163356576186,0.12571827358309,"208"
"R-HSA-389513~Co-inhibition by CTLA4",0.0192307692307692,32.3686908327399,29.9166666666667,0.0329163356576186,0.12571827358309,"208"
"GO:0031290~retinal ganglion cell axon guidance",0.0188679245283019,30.7264627631375,28.4920634920635,0.034534270305188,0.128654310276295,"6152"
"GO:0006337~nucleosome disassembly",0.0188679245283019,30.7264627631375,28.4920634920635,0.034534270305188,0.128654310276295,"6601"
"R-HSA-9609523~Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",0.0188679245283019,30.7264627631375,28.4920634920635,0.034534270305188,0.128654310276295,"9218"
"R-HSA-9824585~Regulation of MITF-M-dependent genes involved in pigmentation",0.0273972602739726,31.6848686737,28.4920634920635,0.00223673219911966,0.0483724375270616,"208, 6601"
"WP5376:17p13 3 YWHAE copy number variation",0.0188679245283019,30.7264627631375,28.4920634920635,0.034534270305188,0.128654310276295,"10971"
"WP497:Urea cycle and metabolism of amino groups",0.0188679245283019,30.7264627631375,28.4920634920635,0.034534270305188,0.128654310276295,"2746"
"GO:0035335~peptidyl-tyrosine dephosphorylation",0.0185185185185185,29.2658782051059,27.1969696969697,0.0361495800334343,0.131439873001567,"1845"
"GO:2000147~positive regulation of cell motility",0.0185185185185185,29.2658782051059,27.1969696969697,0.0361495800334343,0.131439873001567,"208"
"GO:0008138~protein tyrosine/serine/threonine phosphatase activity",0.0185185185185185,29.2658782051059,27.1969696969697,0.0361495800334343,0.131439873001567,"1845"
"R-HSA-198753~ERK/MAPK targets",0.0185185185185185,29.2658782051059,27.1969696969697,0.0361495800334343,0.131439873001567,"1845"
"WP5294:Sildenafil treatment",0.0185185185185185,29.2658782051059,27.1969696969697,0.0361495800334343,0.131439873001567,"208"
"WP268:Notch signaling",0.0263157894736842,29.4753507794381,26.5925925925926,0.00256381533547681,0.0506632204336613,"1488, 1857"
"GO:0030301~cholesterol transport",0.0181818181818182,27.9395084901873,26.0144927536232,0.0377622689681247,0.134611382321668,"9218"
"R-HSA-8949215~Mitochondrial calcium ion transport",0.0181818181818182,27.9395084901873,26.0144927536232,0.0377622689681247,0.134611382321668,"10730"
"hsa00220_Arginine_biosynthesis",0.0181818181818182,27.9395084901873,26.0144927536232,0.0377622689681247,0.134611382321668,"2746"
"hsa04964_Proximal_tubule_bicarbonate_reclamation",0.0181818181818182,27.9395084901873,26.0144927536232,0.0377622689681247,0.134611382321668,"2746"
"GO:0021762~substantia nigra development",0.0253164556962025,27.5567129408905,24.9305555555556,0.00291206955105027,0.0532627691629243,"10971, 2746"
"GO:0051893~regulation of focal adhesion assembly",0.0178571428571429,26.7294395187182,24.9305555555556,0.0393723412287498,0.137124360831163,"1845"
"R-HSA-379716~Cytosolic tRNA aminoacylation",0.0178571428571429,26.7294395187182,24.9305555555556,0.0393723412287498,0.137124360831163,"1615"
"R-HSA-2024096~HS-GAG degradation",0.0178571428571429,26.7294395187182,24.9305555555556,0.0393723412287498,0.137124360831163,"3423"
"R-HSA-9634638~Estrogen-dependent nuclear events downstream of ESR-membrane signaling",0.0178571428571429,26.7294395187182,24.9305555555556,0.0393723412287498,0.137124360831163,"208"
"WP4595:Urea cycle and associated pathways",0.0178571428571429,26.7294395187182,24.9305555555556,0.0393723412287498,0.137124360831163,"2746"
"R-HSA-70268~Pyruvate metabolism",0.025,26.9719183196224,24.421768707483,0.00303282313610373,0.0532627691629243,"54994, 64795"
"GO:0046597~host-mediated suppression of symbiont invasion",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"81603"
"GO:0070316~regulation of G0 to G1 transition",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"6601"
"GO:0097150~neuronal stem cell population maintenance",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"10730"
"R-HSA-392451~G beta:gamma signalling through PI3Kgamma",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"208"
"KW-0321~Glycogen metabolism",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"208"
"WP3872:Regulation of apoptosis by parathyroid hormone related protein",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"208"
"WP26:S1P receptor signal transduction",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"208"
"WP4483:Relationship between inflammation COX 2 and EGFR",0.0175438596491228,25.6204605411606,23.9333333333333,0.0409798009285343,0.137965329792732,"208"
"R-HSA-1445148~Translocation of SLC2A4 (GLUT4) to the plasma membrane",0.0280373831775701,26.5206039674549,23.3116883116883,0.000285979379249192,0.0292298017183013,"10971, 208, 57148"
"GO:0007020~microtubule nucleation",0.0172413793103448,24.5838993816272,23.0128205128205,0.0425846521744444,0.139242621678309,"57606"
"R-HSA-5674400~Constitutive Signaling by AKT1 E17K in Cancer",0.0172413793103448,24.5838993816272,23.0128205128205,0.0425846521744444,0.139242621678309,"208"
"WP5385:Growth factors and hormones in beta cell proliferation",0.0172413793103448,24.5838993816272,23.0128205128205,0.0425846521744444,0.139242621678309,"208"
"WP5494:Tyrosine kinase inhibitors in glioblastoma",0.0172413793103448,24.5838993816272,23.0128205128205,0.0425846521744444,0.139242621678309,"208"
"WP5496:Targeted therapy in breast cancer",0.0172413793103448,24.5838993816272,23.0128205128205,0.0425846521744444,0.139242621678309,"208"
"GO:0035567~non-canonical Wnt signaling pathway",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"1857"
"GO:0046329~negative regulation of JNK cascade",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"1845"
"GO:2000819~regulation of nucleotide-excision repair",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"6601"
"GO:0140677~molecular function activator activity",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"208"
"R-HSA-191273~Cholesterol biosynthesis",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"6721"
"R-HSA-389357~CD28 dependent PI3K/Akt signaling",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"208"
"KW-0699~rRNA-binding",0.0169491525423729,23.6386294833236,22.1604938271605,0.0441868990672003,0.139793209817006,"6191"
"R-HSA-109606~Intrinsic Pathway for Apoptosis",0.0232558139534884,23.9139846440795,21.7575757575758,0.00380583399966852,0.057658385094978,"10971, 208"
"GO:0031116~positive regulation of microtubule polymerization",0.0166666666666667,22.7651009577692,21.3690476190476,0.0457865457012798,0.142047679325814,"57606"
"GO:0007141~male meiosis I",0.0166666666666667,22.7651009577692,21.3690476190476,0.0457865457012798,0.142047679325814,"22887"
"GO:0008143~poly(A) binding",0.0166666666666667,22.7651009577692,21.3690476190476,0.0457865457012798,0.142047679325814,"9987"
"R-HSA-9619665~EGR2 and SOX10-mediated initiation of Schwann cell myelination",0.0166666666666667,22.7651009577692,21.3690476190476,0.0457865457012798,0.142047679325814,"6721"
"GO:0090314~positive regulation of protein targeting to membrane",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"208"
"GO:0006520~amino acid metabolic process",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"2746"
"GO:0016311~dephosphorylation",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"1845"
"GO:0035025~positive regulation of Rho protein signal transduction",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"10276"
"R-HSA-8863795~Downregulation of ERBB2 signaling",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"208"
"R-HSA-5218920~VEGFR2 mediated vascular permeability",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"208"
"WP3965:Lipid metabolism pathway",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"208"
"WP5351:Kleefstra syndrome",0.0163934426229508,21.9494570715567,20.632183908046,0.0473835961649333,0.142621486469948,"6601"
"WP477:Cytoplasmic ribosomal proteins",0.0254237288135593,23.0519596425239,20.3977272727273,0.000423679666134687,0.0292298017183013,"6152, 6165, 6191"
"R-HSA-2408522~Selenoamino acid metabolism",0.0272108843537415,23.6753715748569,20.2824858757062,4.33779275661457e-05,0.0292298017183013,"1615, 6152, 6165, 6191"
"R-HSA-192823~Viral mRNA Translation",0.025,22.5226293288958,19.9444444444444,0.000452548429478299,0.0292298017183013,"6152, 6165, 6191"
"R-HSA-156902~Peptide chain elongation",0.025,22.5226293288958,19.9444444444444,0.000452548429478299,0.0292298017183013,"6152, 6165, 6191"
"KW-0820~tRNA-binding",0.0161290322580645,21.1924691157476,19.9444444444444,0.0489780545401904,0.14645082755603,"6165"
"WP5102:Familial partial lipodystrophy",0.0161290322580645,21.1924691157476,19.9444444444444,0.0489780545401904,0.14645082755603,"208"
"GO:0002181~cytoplasmic translation",0.0247933884297521,22.2694254914501,19.7252747252747,0.000467444576210885,0.0292298017183013,"6152, 6165, 6191"
"GO:0050860~negative regulation of T cell receptor signaling pathway",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"1845"
"GO:0000993~RNA polymerase II complex binding",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"51322"
"R-HSA-4641262~Disassembly of the destruction complex and recruitment of AXIN to the membrane",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"1857"
"R-HSA-6804758~Regulation of TP53 Activity through Acetylation",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"208"
"R-HSA-450282~MAPK targets/ Nuclear events mediated by MAP kinases",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"1845"
"WP4204:Tumor suppressor activity of SMARCB1",0.0158730158730159,20.4757505379633,19.3010752688172,0.0505699249028664,0.148284070118405,"6601"
"hsa04330_Notch_signaling_pathway",0.021505376344086,21.1057089500766,19.3010752688172,0.00481113774501951,0.0623325647387203,"1488, 1857"
"R-HSA-156842~Eukaryotic Translation Elongation",0.0241935483870968,21.5388133563192,19.0957446808511,0.000514012864385892,0.0292298017183013,"6152, 6165, 6191"
"R-HSA-72764~Eukaryotic Translation Termination",0.0241935483870968,21.5388133563192,19.0957446808511,0.000514012864385892,0.0292298017183013,"6152, 6165, 6191"
"R-HSA-2408557~Selenocysteine synthesis",0.0241935483870968,21.5388133563192,19.0957446808511,0.000514012864385892,0.0292298017183013,"6152, 6165, 6191"
"GO:0016239~positive regulation of macroautophagy",0.015625,19.8197563845223,18.6979166666667,0.0521592113225792,0.151478348537458,"51322"
"R-HSA-397795~G-protein beta:gamma signalling",0.015625,19.8197563845223,18.6979166666667,0.0521592113225792,0.151478348537458,"208"
"R-HSA-975956~Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)",0.0238095238095238,21.075440908832,18.6979166666667,0.000546651957327967,0.0292298017183013,"6152, 6165, 6191"
"WP5312:Metabolic pathways of fibroblasts",0.015625,19.8197563845223,18.6979166666667,0.0521592113225792,0.151478348537458,"2746"
"GO:0006891~intra-Golgi vesicle-mediated transport",0.0153846153846154,19.1974416447409,18.1313131313131,0.0537459178627482,0.153150593533662,"8774"
"GO:0071889~14-3-3 protein binding",0.0153846153846154,19.1974416447409,18.1313131313131,0.0537459178627482,0.153150593533662,"10971"
"R-HSA-9614085~FOXO-mediated transcription",0.0206185567010309,19.78018029002,18.1313131313131,0.00543468944205721,0.0658684360377334,"10971, 208"
"WP4481:Resistin as a regulator of inflammation",0.0153846153846154,19.1974416447409,18.1313131313131,0.0537459178627482,0.153150593533662,"208"
"WP5490:Inhibition of GNAQ regulated signaling in uveal melanoma",0.0153846153846154,19.1974416447409,18.1313131313131,0.0537459178627482,0.153150593533662,"208"
"GO:0060071~Wnt signaling pathway, planar cell polarity pathway",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"1857"
"GO:0030071~regulation of mitotic metaphase/anaphase transition",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"6601"
"GO:0043495~protein-membrane adaptor activity",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"9218"
"R-HSA-9633012~Response of EIF2AK4 (GCN2) to amino acid deficiency",0.0227272727272727,19.7984402000321,17.5980392156863,0.000652452334127408,0.0312146932485165,"6152, 6165, 6191"
"R-HSA-5663084~Diseases of carbohydrate metabolism",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"3423"
"R-HSA-4791275~Signaling by WNT in cancer",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"1488"
"R-HSA-72689~Formation of a pool of free 40S subunits",0.0227272727272727,19.7984402000321,17.5980392156863,0.000652452334127408,0.0312146932485165,"6152, 6165, 6191"
"WP5358:JAK STAT signaling in the regulation of beta cells",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"208"
"WP4542:Leukocyte intrinsic Hippo pathway functions",0.0151515151515152,18.625698257277,17.5980392156863,0.0553300485806122,0.154279184539192,"10971"
"GO:0045931~positive regulation of mitotic cell cycle",0.0149253731343284,18.0732137703625,17.0952380952381,0.0569116075272329,0.157242101040288,"1845"
"GO:0040018~positive regulation of multicellular organism growth",0.0149253731343284,18.0732137703625,17.0952380952381,0.0569116075272329,0.157242101040288,"23637"
"GO:1903955~positive regulation of protein targeting to mitochondrion",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"6721"
"GO:0046326~positive regulation of D-glucose import",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"208"
"GO:0042273~ribosomal large subunit biogenesis",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"6165"
"GO:0051287~NAD binding",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"1488"
"R-HSA-6804757~Regulation of TP53 Degradation",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"208"
"R-HSA-1660661~Sphingolipid de novo biosynthesis",0.0147058823529412,17.5550922561893,16.6203703703704,0.0584905987475069,0.157768410271465,"9218"
"GO:0007249~canonical NF-kappaB signal transduction",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"81603"
"GO:0045582~positive regulation of T cell differentiation",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"6601"
"GO:0090630~activation of GTPase activity",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"57148"
"GO:0001221~transcription coregulator binding",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"1488"
"R-HSA-6806003~Regulation of TP53 Expression and Degradation",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"208"
"R-HSA-9735869~SARS-CoV-1 modulates host translation machinery",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"6191"
"WP4150:Wnt signaling in kidney disease",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"1857"
"hsa00250_Alanine,_aspartate_and_glutamate_metabolism",0.0144927536231884,17.066706245262,16.1711711711712,0.0600670262801739,0.157806147077104,"2746"
"R-HSA-156827~L13a-mediated translational silencing of Ceruloplasmin expression",0.0211267605633803,17.9607613682997,16.0267857142857,0.000856303090682064,0.0352013090480694,"6152, 6165, 6191"
"R-HSA-1799339~SRP-dependent cotranslational protein targeting to membrane",0.020979020979021,17.8023575771128,15.8849557522124,0.000878658336750434,0.0352013090480694,"6152, 6165, 6191"
"R-HSA-72706~GTP hydrolysis and joining of the 60S ribosomal subunit",0.020979020979021,17.8023575771128,15.8849557522124,0.000878658336750434,0.0352013090480694,"6152, 6165, 6191"
"GO:0007095~mitotic G2 DNA damage checkpoint signaling",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"1112"
"GO:0005109~frizzled binding",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"1857"
"R-HSA-8939243~RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"6601"
"R-HSA-9607240~FLT3 Signaling",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"208"
"KW-0030~Aminoacyl-tRNA synthetase",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"1615"
"WP2036:TNF related weak inducer of apoptosis TWEAK signaling",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"208"
"WP5215:Targeted agents in triple negative breast cancer",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"208"
"WP5497:Cyclin dependent kinase 4 6 inhibitors in breast cancer",0.0142857142857143,16.6039262679661,15.7456140350877,0.0616408941578251,0.157895289728617,"208"
"GO:0001558~regulation of cell growth",0.0185185185185185,16.8791521633394,15.5411255411255,0.00732910753587916,0.0740239861123796,"10276, 51232"
"hsa05220_Chronic_myeloid_leukemia",0.0185185185185185,16.8791521633394,15.5411255411255,0.00732910753587916,0.0740239861123796,"1488, 208"
"R-HSA-975957~Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",0.0205479452054795,17.3302115804801,15.4741379310345,0.000947941809406956,0.0352013090480694,"6152, 6165, 6191"
"R-HSA-927802~Nonsense-Mediated Decay (NMD)",0.0205479452054795,17.3302115804801,15.4741379310345,0.000947941809406956,0.0352013090480694,"6152, 6165, 6191"
"GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process",0.0140845070422535,16.1628427002247,15.3418803418803,0.0632122064069136,0.160055419565138,"51322"
"GO:0043531~ADP binding",0.0140845070422535,16.1628427002247,15.3418803418803,0.0632122064069136,0.160055419565138,"2746"
"R-HSA-8950505~Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",0.0140845070422535,16.1628427002247,15.3418803418803,0.0632122064069136,0.160055419565138,"9987"
"WP4871:Kisspeptin kisspeptin receptor system in the ovary",0.0140845070422535,16.1628427002247,15.3418803418803,0.0632122064069136,0.160055419565138,"208"
"GO:0008286~insulin receptor signaling pathway",0.0202702702702703,17.0371133917767,15.2118644067797,0.000996002797763395,0.0352013090480694,"208, 23637, 64397"
"GO:1900182~positive regulation of protein localization to nucleus",0.0138888888888889,15.7524651504609,14.9583333333333,0.0647809670477626,0.161774447929715,"81603"
"GO:0019827~stem cell population maintenance",0.0138888888888889,15.7524651504609,14.9583333333333,0.0647809670477626,0.161774447929715,"81603"
"R-HSA-72737~Cap-dependent Translation Initiation",0.02,16.7359357979545,14.9583333333333,0.00104558343707137,0.0352013090480694,"6152, 6165, 6191"
"R-HSA-72613~Eukaryotic Translation Initiation",0.02,16.7359357979545,14.9583333333333,0.00104558343707137,0.0352013090480694,"6152, 6165, 6191"
"KW-0762~Sugar transport",0.0138888888888889,15.7524651504609,14.9583333333333,0.0647809670477626,0.161774447929715,"208"
"WP4564:Neural crest cell migration during development",0.0138888888888889,15.7524651504609,14.9583333333333,0.0647809670477626,0.161774447929715,"208"
"GO:0015914~phospholipid transport",0.0136986301369863,15.3583032771781,14.5934959349593,0.0663471800945742,0.163440614379317,"9218"
"GO:0071479~cellular response to ionizing radiation",0.0136986301369863,15.3583032771781,14.5934959349593,0.0663471800945742,0.163440614379317,"10276"
"GO:0031492~nucleosomal DNA binding",0.0136986301369863,15.3583032771781,14.5934959349593,0.0663471800945742,0.163440614379317,"6601"
"R-HSA-5628897~TP53 Regulates Metabolic Genes",0.0176991150442478,15.8214398639432,14.5934959349593,0.00827538126212346,0.0772603695900188,"10971, 208"
"R-HSA-2426168~Activation of gene expression by SREBF (SREBP)",0.0136986301369863,15.3583032771781,14.5934959349593,0.0663471800945742,0.163440614379317,"6721"
"R-HSA-186712~Regulation of beta-cell development",0.0136986301369863,15.3583032771781,14.5934959349593,0.0663471800945742,0.163440614379317,"208"
"GO:0043087~regulation of GTPase activity",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"23637"
"R-HSA-379724~tRNA Aminoacylation",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"1615"
"R-HSA-3769402~Deactivation of the beta-catenin transactivating complex",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"208"
"R-HSA-165159~MTOR signalling",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"208"
"R-HSA-109704~PI3K Cascade",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"208"
"WP5220:Metabolic reprogramming in pancreatic cancer",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"2746"
"WP4290:Metabolic reprogramming in colon cancer",0.0135135135135135,14.9835447788982,14.2460317460317,0.0679108495554386,0.164178091079504,"2746"
"GO:0009267~cellular response to starvation",0.0172413793103448,15.2481609477172,14.078431372549,0.00886815548795262,0.0814257912984741,"10730, 6721"
"GO:0019843~rRNA binding",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323447,0.166622768612141,"6191"
"WP4565:Neural crest cell migration in cancer",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323447,0.166622768612141,"208"
"WP4336:ncRNAs in Wnt signaling in hepatocellular carcinoma",0.0170940170940171,15.0662680813056,13.9147286821705,0.00906987290760427,0.0821339274841202,"1488, 1857"
"GO:0043547~positive regulation of GTPase activity",0.0169491525423729,14.8887080898134,13.7547892720307,0.00927364164583307,0.0825314866648407,"10276, 1857"
"GO:0006605~protein targeting",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211849,0.168223315104907,"10971"
"GO:0046627~negative regulation of insulin receptor signaling pathway",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211849,0.168223315104907,"23637"
"R-HSA-4641258~Degradation of DVL",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211849,0.168223315104907,"1857"
"hsa00970_Aminoacyl-tRNA_biosynthesis",0.0131578947368421,14.2869951508904,13.5984848484848,0.0710305737211849,0.168223315104907,"1615"
"GO:0045663~positive regulation of myoblast differentiation",0.012987012987013,13.9628028119623,13.2962962962963,0.0725866364117691,0.17005477448015,"6601"
"GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",0.012987012987013,13.9628028119623,13.2962962962963,0.0725866364117691,0.17005477448015,"1488"
"WP5493:Effect of dasatinib on the BCR ABL signaling pathway",0.012987012987013,13.9628028119623,13.2962962962963,0.0725866364117691,0.17005477448015,"208"
"hsa03010_Ribosome",0.0181818181818182,14.8261676892245,13.2962962962963,0.00146772444761175,0.0397610503897186,"6152, 6165, 6191"
"R-HSA-168273~Influenza Viral RNA Transcription and Replication",0.0179640718562874,14.604133298355,13.1021897810219,0.0015309535353577,0.0397610503897186,"6152, 6165, 6191"
"GO:0043409~negative regulation of MAPK cascade",0.0128205128205128,13.6532008554008,13.0072463768116,0.0741401714878309,0.17157926503909,"1845"
"GO:0071364~cellular response to epidermal growth factor stimulus",0.0128205128205128,13.6532008554008,13.0072463768116,0.0741401714878309,0.17157926503909,"1845"
"R-HSA-112399~IRS-mediated signalling",0.0128205128205128,13.6532008554008,13.0072463768116,0.0741401714878309,0.17157926503909,"208"
"WP4566:Translation inhibitors in chronically activated PDGFRA cells",0.0128205128205128,13.6532008554008,13.0072463768116,0.0741401714878309,0.17157926503909,"208"
"GO:0031122~cytoplasmic microtubule organization",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"57606"
"GO:2000781~positive regulation of double-strand break repair",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"6601"
"GO:0019905~syntaxin binding",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"8774"
"R-HSA-6811438~Intra-Golgi traffic",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"8774"
"R-HSA-389356~Co-stimulation by CD28",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"208"
"R-HSA-8854214~TBC/RABGAPs",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"23637"
"WP363:Wnt signaling",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"1857"
"WP4258:lncRNA in canonical Wnt signaling and colorectal cancer",0.016,13.7550411414273,12.7304964539007,0.010756874843908,0.0873035645813605,"1488, 1857"
"WP4718:Cholesterol metabolism with Bloch and Kandutsch Russell pathways",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"6721"
"WP4534:Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms",0.0126582278481013,13.357190024079,12.7304964539007,0.0756911829270355,0.17157926503909,"10971"
"R-HSA-9020591~Interleukin-12 signaling",0.0125,13.0634241176361,12.4652777777778,0.0772396747009932,0.173789268077235,"9987"
"WP410:Exercise induced circadian regulation",0.0125,13.0634241176361,12.4652777777778,0.0772396747009932,0.173789268077235,"9218"
"WP5053:Development of ureteric derived collecting system",0.0125,13.0634241176361,12.4652777777778,0.0772396747009932,0.173789268077235,"51232"
"R-HSA-9837999~Mitochondrial protein degradation",0.0155038759689922,13.1713192979496,12.2108843537415,0.01164849804233,0.0882373726706501,"10730, 2746"
"WP286:IL3 signaling",0.0123456790123457,12.7923322198824,12.2108843537415,0.0787856507752618,0.176801853836341,"10971"
"GO:0001222~transcription corepressor binding",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"1488"
"GO:0016791~phosphatase activity",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"1845"
"R-HSA-9692914~SARS-CoV-1-host interactions",0.0152671755725191,12.902701526917,11.9666666666667,0.0121061481924993,0.0901868134793485,"10971, 6191"
"R-HSA-1227986~Signaling by ERBB2",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"208"
"R-HSA-2428924~IGF1R signaling cascade",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"208"
"R-HSA-2428928~IRS-related events triggered by IGF1R",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"208"
"WP2018:RANKL RANK signaling",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"208"
"WP5373:Osteoarthritic chondrocyte hypertrophy",0.0121951219512195,12.5322594416864,11.9666666666667,0.0803291151093606,0.176801853836341,"208"
"WP2064:Neural crest differentiation",0.0151515151515152,12.7724334461826,11.8481848184818,0.0123379091158926,0.0901868134793485,"1488, 1857"
"GO:1990782~protein tyrosine kinase binding",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"1845"
"R-HSA-6811440~Retrograde transport at the Trans-Golgi-Network",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"8774"
"R-HSA-1793185~Chondroitin sulfate/dermatan sulfate metabolism",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"3423"
"R-HSA-2404192~Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"208"
"R-HSA-9754678~SARS-CoV-2 modulates host translation machinery",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"6191"
"WP399:Wnt signaling and pluripotency",0.0150375939849624,12.6447452046098,11.7320261437908,0.012571618251528,0.0901868134793485,"1488, 1857"
"WP4539:Synaptic signaling associated with autism spectrum disorder",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"208"
"hsa04979_Cholesterol_metabolism",0.0120481927710843,12.2817743039957,11.7320261437908,0.0818700716567784,0.177190226514313,"9218"
"GO:0006412~translation",0.0170940170940171,13.3773695290793,11.6747967479675,0.000364674219915573,0.0292298017183013,"1615, 6152, 6165, 6191"
"R-HSA-9730414~MITF-M-regulated melanocyte development",0.0162162162162162,12.8613072375312,11.5806451612903,0.00217794140391677,0.0483724375270616,"1615, 208, 6601"
"GO:0045668~negative regulation of osteoblast differentiation",0.0119047619047619,12.0405095278654,11.5064102564103,0.0834085243649805,0.178816860018319,"51232"
"R-HSA-9856651~MITF-M-dependent gene expression",0.0148148148148148,12.3967096380833,11.5064102564103,0.0130448541952712,0.0901868134793485,"208, 6601"
"R-HSA-72695~Formation of the ternary complex, and subsequently, the 43S complex",0.0119047619047619,12.0405095278654,11.5064102564103,0.0834085243649805,0.178816860018319,"6191"
"R-HSA-74751~Insulin receptor signalling cascade",0.0119047619047619,12.0405095278654,11.5064102564103,0.0834085243649805,0.178816860018319,"208"
"hsa04973_Carbohydrate_digestion_and_absorption",0.0119047619047619,12.0405095278654,11.5064102564103,0.0834085243649805,0.178816860018319,"208"
"R-HSA-9711097~Cellular response to starvation",0.0160427807486631,12.6930782722528,11.4331210191083,0.00225877790301657,0.0483724375270616,"6152, 6165, 6191"
"R-HSA-168255~Influenza Infection",0.0159574468085106,12.6105915650893,11.3607594936709,0.00229988737623578,0.0483724375270616,"6152, 6165, 6191"
"GO:0008092~cytoskeletal protein binding",0.0117647058823529,11.8085029299445,11.2893081761006,0.0849444771754185,0.180407779795457,"1845"
"GO:0005010~insulin-like growth factor receptor activity",0.0117647058823529,11.8085029299445,11.2893081761006,0.0849444771754185,0.180407779795457,"51232"
"R-HSA-9010553~Regulation of expression of SLITs and ROBOs",0.0158730158730159,12.5291621833188,11.2893081761006,0.00234146012232201,0.0483724375270616,"6152, 6165, 6191"
"WP2864:Apoptosis related network due to altered Notch3 in ovarian cancer",0.0117647058823529,11.8085029299445,11.2893081761006,0.0849444771754185,0.180407779795457,"10276"
"WP5144:NRP1 triggered signaling in pancreatic cancer ",0.0117647058823529,11.8085029299445,11.2893081761006,0.0849444771754185,0.180407779795457,"208"
"GO:0003735~structural constituent of ribosome",0.0157068062827225,12.3693949863864,11.1490683229814,0.00242600273253211,0.0490052551971487,"6152, 6165, 6191"
"WP4352:Ciliary landscape",0.0163934426229508,12.741105946231,11.1317829457364,0.000436660304505717,0.0292298017183013,"1488, 1857, 54994, 64795"
"GO:2000045~regulation of G1/S transition of mitotic cell cycle",0.0116279069767442,11.5852516925167,11.0802469135802,0.0864779340235398,0.181963986174532,"6601"
"R-HSA-1655829~Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.0116279069767442,11.5852516925167,11.0802469135802,0.0864779340235398,0.181963986174532,"6721"
"WP2795:Cardiac hypertrophic response",0.0116279069767442,11.5852516925167,11.0802469135802,0.0864779340235398,0.181963986174532,"208"
"GO:1904263~positive regulation of TORC1 signaling",0.0114942528735632,11.3702680221058,10.8787878787879,0.0880088988387961,0.183908250676933,"51322"
"WP2272:Pathogenic Escherichia coli infection",0.0114942528735632,11.3702680221058,10.8787878787879,0.0880088988387961,0.183908250676933,"10971"
"WP710:DNA damage response only ATM dependent ",0.0141843971631206,11.7048326562453,10.8787878787879,0.0145106209051643,0.0943379363472736,"1857, 208"
"R-HSA-8948751~Regulation of PTEN stability and activity",0.0113636363636364,11.1630996536018,10.6845238095238,0.0895373755446535,0.185820717739932,"208"
"R-HSA-2151201~Transcriptional activation of mitochondrial biogenesis",0.0113636363636364,11.1630996536018,10.6845238095238,0.0895373755446535,0.185820717739932,"2746"
"hsa05225_Hepatocellular_carcinoma",0.0150753768844221,11.7688118049412,10.6213017751479,0.00278306384054312,0.0532627691629243,"1857, 208, 6601"
"WP428:Wnt signaling",0.0137931034482759,11.2847523432381,10.4970760233918,0.0155256490998027,0.0973297588394529,"1488, 1857"
"GO:0070534~protein K63-linked ubiquitination",0.0111111111111111,10.772098498626,10.316091954023,0.0925868802921432,0.189676487319563,"81603"
"GO:0000381~regulation of alternative mRNA splicing, via spliceosome",0.0111111111111111,10.772098498626,10.316091954023,0.0925868802921432,0.189676487319563,"55082"
"R-HSA-447115~Interleukin-12 family signaling",0.0111111111111111,10.772098498626,10.316091954023,0.0925868802921432,0.189676487319563,"9987"
"R-HSA-1638091~Heparan sulfate/heparin (HS-GAG) metabolism",0.0111111111111111,10.772098498626,10.316091954023,0.0925868802921432,0.189676487319563,"3423"
"GO:0032024~positive regulation of insulin secretion",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"2746"
"GO:0002376~immune system process",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"5763"
"GO:0070888~E-box binding",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"6721"
"R-HSA-72649~Translation initiation complex formation",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"6191"
"R-HSA-72702~Ribosomal scanning and start codon recognition",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"6191"
"R-HSA-8866654~E3 ubiquitin ligases ubiquitinate target proteins",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"51322"
"WP3931:Embryonic stem cell pluripotency pathways",0.0134228187919463,10.8950155247986,10.1412429378531,0.0165704657409687,0.0985742559360228,"1857, 208"
"WP4205:MET in type 1 papillary renal cell carcinoma",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"208"
"hsa04923_Regulation_of_lipolysis_in_adipocytes",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"208"
"hsa05213_Endometrial_cancer",0.010989010989011,10.5859837508472,10.1412429378531,0.0941079161508502,0.189676487319563,"208"
"GO:0051056~regulation of small GTPase mediated signal transduction",0.0133333333333333,10.8014060910725,10.0560224089636,0.0168362753777329,0.0987366085055433,"10276, 57148"
"WP4657:22q11 2 copy number variation syndrome",0.0133333333333333,10.8014060910725,10.0560224089636,0.0168362753777329,0.0987366085055433,"2746, 6721"
"GO:0030514~negative regulation of BMP signaling pathway",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"51232"
"GO:0045597~positive regulation of cell differentiation",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"6601"
"R-HSA-193648~NRAGE signals death through JNK",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"10276"
"R-HSA-72662~Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"6191"
"WP5352:10q11 21q11 23 copy number variation syndrome",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"6601"
"WP5470:Effect of omega 3 PUFA on Huntington 39 s disease pathways",0.0132450331125828,10.7091732992175,9.97222222222222,0.0171039142241848,0.0992123849108804,"208, 6721"
"hsa04370_VEGF_signaling_pathway",0.0108695652173913,10.4061494526668,9.97222222222222,0.0956264795343217,0.189791418988424,"208"
"GO:1902895~positive regulation of miRNA transcription",0.010752688172043,10.231734415322,9.80874316939891,0.0971425743362201,0.191962174068748,"6721"
"R-HSA-198725~Nuclear Events (kinase and transcription factor activation)",0.010752688172043,10.231734415322,9.80874316939891,0.0971425743362201,0.191962174068748,"1845"
"GO:0000987~cis-regulatory region sequence-specific DNA binding",0.0106382978723404,10.0602714849806,9.6505376344086,0.0986562044442728,0.192856967397514,"1112"
"R-HSA-9856649~Transcriptional and post-translational regulation of MITF-M expression and activity",0.0106382978723404,10.0602714849806,9.6505376344086,0.0986562044442728,0.192856967397514,"1615"
"R-HSA-6791226~Major pathway of rRNA processing in the nucleolus and cytosol",0.0138888888888889,10.6655783805159,9.6505376344086,0.00364544152397167,0.0561645143269534,"6152, 6165, 6191"
"KW-0689~Ribosomal protein",0.0138888888888889,10.6655783805159,9.6505376344086,0.00364544152397167,0.0561645143269534,"6152, 6165, 6191"
"WP5402:10q22q23 copy number variation",0.0106382978723404,10.0602714849806,9.6505376344086,0.0986562044442728,0.192856967397514,"2746"
"hsa04213_Longevity_regulating_pathway",0.0106382978723404,10.0602714849806,9.6505376344086,0.0986562044442728,0.192856967397514,"208"
"R-HSA-9007101~Rab regulation of trafficking",0.0128205128205128,10.2690731808591,9.57333333333333,0.0184693209153041,0.101136221156695,"208, 23637"
"GO:0006006~glucose metabolic process",0.0105263157894737,9.89869510465019,9.4973544973545,0.100167373740282,0.19372796325514,"208"
"R-HSA-450294~MAP kinase activation",0.0105263157894737,9.89869510465019,9.4973544973545,0.100167373740282,0.19372796325514,"1845"
"WP4155:Endometrial cancer",0.0105263157894737,9.89869510465019,9.4973544973545,0.100167373740282,0.19372796325514,"208"
"WP5504:Disorders of mitochondrial homeostatis dynamics protein import and quality control",0.0105263157894737,9.89869510465019,9.4973544973545,0.100167373740282,0.19372796325514,"10730"
"hsa05217_Basal_cell_carcinoma",0.0105263157894737,9.89869510465019,9.4973544973545,0.100167373740282,0.19372796325514,"1857"
"GO:0070301~cellular response to hydrogen peroxide",0.0104166666666667,9.74175384836294,9.34895833333333,0.101676086100131,0.196228369989425,"10276"
"GO:0030971~receptor tyrosine kinase binding",0.0103092783505155,9.58943776372012,9.2051282051282,0.1031823453938,0.198293344530579,"1845"
"hsa04929_GnRH_secretion",0.0103092783505155,9.58943776372012,9.2051282051282,0.1031823453938,0.198293344530579,"208"
"R-HSA-8868773~rRNA processing in the nucleus and cytosol",0.0132743362831858,10.1085988885337,9.15816326530612,0.00422107787316898,0.0618864481727517,"6152, 6165, 6191"
"GO:0060041~retina development in camera-type eye",0.0102040816326531,9.44165446030132,9.06565656565657,0.104686155485365,0.200336242813046,"6152"
"KW-0153~Cholesterol metabolism",0.0102040816326531,9.44165446030132,9.06565656565657,0.104686155485365,0.200336242813046,"6721"
"WP3915:Angiopoietin like protein 8 regulatory pathway",0.0122699386503067,9.71312178580956,9.06565656565657,0.0204559213180802,0.107482268659739,"208, 6721"
"WP1403:AMP activated protein kinase signaling",0.0101010101010101,9.29631926482886,8.93034825870647,0.106187520233014,0.201934008141862,"208"
"R-HSA-9705683~SARS-CoV-2-host interactions",0.0128755364806867,9.75355681255738,8.8423645320197,0.0046551530467396,0.0623325647387203,"10971, 208, 6191"
"GO:0015631~tubulin binding",0.01,9.16089936354731,8.79901960784314,0.107686443489052,0.203507228963717,"23637"
"WP4685:Melanoma",0.01,9.16089936354731,8.79901960784314,0.107686443489052,0.203507228963717,"208"
"hsa05221_Acute_myeloid_leukemia",0.01,9.16089936354731,8.79901960784314,0.107686443489052,0.203507228963717,"208"
"R-HSA-72312~rRNA processing",0.0127118644067797,9.60730455852718,8.71359223300971,0.00484917189835754,0.0623325647387203,"6152, 6165, 6191"
"R-HSA-376176~Signaling by ROBO receptors",0.0126582278481013,9.55958239545699,8.67149758454106,0.00491491951089659,0.0623325647387203,"6152, 6165, 6191"
"WP1982:Sterol regulatory element binding proteins SREBP signaling",0.0099009900990099,9.02493041041015,8.67149758454106,0.10918292909991,0.20463357227179,"6721"
"WP5293:Acute myeloid leukemia",0.0099009900990099,9.02493041041015,8.67149758454106,0.10918292909991,0.20463357227179,"208"
"hsa04664_Fc_epsilon_RI_signaling_pathway",0.0099009900990099,9.02493041041015,8.67149758454106,0.10918292909991,0.20463357227179,"208"
"GO:0070373~negative regulation of ERK1 and ERK2 cascade",0.00980392156862745,8.8932723577594,8.54761904761905,0.110676980906157,0.205736964506537,"1845"
"R-HSA-195253~Degradation of beta-catenin by the destruction complex",0.00980392156862745,8.8932723577594,8.54761904761905,0.110676980906157,0.205736964506537,"1488"
"hsa04920_Adipocytokine_signaling_pathway",0.00980392156862745,8.8932723577594,8.54761904761905,0.110676980906157,0.205736964506537,"208"
"hsa05211_Renal_cell_carcinoma",0.00980392156862745,8.8932723577594,8.54761904761905,0.110676980906157,0.205736964506537,"208"
"GO:0003713~transcription coactivator activity",0.0128617363344051,9.63627291349066,8.48699763593381,0.00120269306094635,0.0376982066344909,"1488, 55082, 6601, 81603"
"WP2853:Endoderm differentiation",0.0116279069767442,9.08144663498255,8.48699763593381,0.0231355654091321,0.111356696936647,"1112, 1488"
"R-HSA-71291~Metabolism of amino acids and derivatives",0.0130890052356021,9.902021242797,8.45103578154426,0.000282796167447866,0.0292298017183013,"1615, 2746, 6152, 6165, 6191"
"GO:0010506~regulation of autophagy",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"51322"
"R-HSA-9013026~RHOB GTPase cycle",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"10276"
"R-HSA-448424~Interleukin-17 signaling",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"1845"
"R-HSA-204005~COPII-mediated vesicle transport",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"8774"
"hsa04917_Prolactin_signaling_pathway",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"208"
"hsa05230_Central_carbon_metabolism_in_cancer",0.00970873786407767,8.76559719431319,8.42723004694836,0.112168602742502,0.20598234321805,"208"
"GO:0019904~protein domain specific binding",0.0121951219512195,9.15021034778768,8.31018518518519,0.00553107794545505,0.0661546033212979,"10971, 9218, 9522"
"WP4255:Non small cell lung cancer",0.00961538461538462,8.6416426508773,8.31018518518519,0.11365779843781,0.207459716425642,"208"
"WP2572:Primary focal segmental glomerulosclerosis FSGS ",0.00961538461538462,8.6416426508773,8.31018518518519,0.11365779843781,0.207459716425642,"10971"
"WP5304:Cholesterol metabolism",0.00961538461538462,8.6416426508773,8.31018518518519,0.11365779843781,0.207459716425642,"9218"
"hsa04550_Signaling_pathways_regulating_pluripotency_of_stem_cells",0.0114285714285714,8.88813487731194,8.31018518518519,0.0240594317122476,0.115105386454911,"1857, 208"
"GO:0065003~protein-containing complex assembly",0.0113636363636364,8.8255333214741,8.25287356321839,0.0243707396003181,0.115380220295256,"1615, 8774"
"R-HSA-9678108~SARS-CoV-1 Infection",0.0113636363636364,8.8255333214741,8.25287356321839,0.0243707396003181,0.115380220295256,"10971, 6191"
"R-HSA-69202~Cyclin E associated events during G1/S transition ",0.00952380952380952,8.52119451914394,8.19634703196347,0.115144571815107,0.208084325606227,"208"
"WP4216:Chromosomal and microsatellite instability in colorectal cancer ",0.00952380952380952,8.52119451914394,8.19634703196347,0.115144571815107,0.208084325606227,"208"
"WP4674:Head and neck squamous cell carcinoma",0.00952380952380952,8.52119451914394,8.19634703196347,0.115144571815107,0.208084325606227,"208"
"hsa05218_Melanoma",0.00952380952380952,8.52119451914394,8.19634703196347,0.115144571815107,0.208084325606227,"208"
"hsa05223_Non-small_cell_lung_cancer",0.00952380952380952,8.52119451914394,8.19634703196347,0.115144571815107,0.208084325606227,"208"
"R-HSA-72766~Translation",0.0124223602484472,9.26641832497701,8.16837315130831,0.00138476591100695,0.0397610503897186,"1615, 6152, 6165, 6191"
"KW-1207~Sterol metabolism",0.00943396226415094,8.40442663108838,8.08558558558559,0.116628926691586,0.209103933654146,"6721"
"hsa05224_Breast_cancer",0.0111731843575419,8.64375251756931,8.08558558558559,0.0253146353795692,0.1174030793879,"1857, 208"
"hsa05226_Gastric_cancer",0.0111111111111111,8.58195816490738,8.03131991051454,0.0256325711448573,0.117716681426429,"1857, 208"
"R-HSA-69656~Cyclin A:Cdk2-associated events at S phase entry",0.00934579439252336,8.28955942333336,7.97777777777778,0.118110866878622,0.210515250966014,"208"
"R-HSA-388841~Regulation of T cell activation by CD28 family",0.00934579439252336,8.28955942333336,7.97777777777778,0.118110866878622,0.210515250966014,"208"
"KW-0687~Ribonucleoprotein",0.0121580547112462,9.04379752706258,7.97777777777778,0.0015102032857468,0.0397610503897186,"6152, 6165, 6191, 9987"
"hsa01524_Platinum_drug_resistance",0.00934579439252336,8.28955942333336,7.97777777777778,0.118110866878622,0.210515250966014,"208"
"WP4666:Hepatitis B infection",0.010989010989011,8.46763737282292,7.92494481236203,0.0262733622271655,0.117716681426429,"10971, 208"
"GO:0042274~ribosomal small subunit biogenesis",0.00925925925925926,8.1790510633379,7.87280701754386,0.119590396181774,0.211493521652203,"6191"
"R-HSA-9009391~Extra-nuclear estrogen signaling",0.00925925925925926,8.1790510633379,7.87280701754386,0.119590396181774,0.211493521652203,"208"
"WP4656:Joubert syndrome",0.00925925925925926,8.1790510633379,7.87280701754386,0.119590396181774,0.211493521652203,"1857"
"hsa05214_Glioma",0.00925925925925926,8.1790510633379,7.87280701754386,0.119590396181774,0.211493521652203,"208"
"R-HSA-204998~Cell death signalling via NRAGE, NRIF and NADE",0.00917431192660551,8.07293118676502,7.77056277056277,0.121067518400799,0.212934568753995,"10276"
"hsa05212_Pancreatic_cancer",0.00917431192660551,8.07293118676502,7.77056277056277,0.121067518400799,0.212934568753995,"208"
"WP4262:Breast cancer pathway",0.010752688172043,8.24486763787479,7.72043010752688,0.0275744546467336,0.117730763400105,"1857, 208"
"GO:0045727~positive regulation of translation",0.00909090909090909,7.96604672095642,7.67094017094017,0.122542237329657,0.214213257178189,"6191"
"hsa04150_mTOR_signaling_pathway",0.0106382978723404,8.13752127484918,7.62208067940552,0.0282346605293982,0.117730763400105,"1857, 208"
"hsa04390_Hippo_signaling_pathway",0.0106382978723404,8.13752127484918,7.62208067940552,0.0282346605293982,0.117730763400105,"10971, 1857"
"hsa05171_Coronavirus_disease",0.0112781954887218,8.35725738877031,7.60593220338983,0.00706123658272241,0.0737777477436169,"6152, 6165, 6191"
"GO:0050821~protein stabilization",0.0112359550561798,8.32113344276466,7.57383966244726,0.00714368895127218,0.0737910597353002,"1857, 208, 8774"
"R-HSA-4086400~PCP/CE pathway",0.00900900900900901,7.8635694761092,7.57383966244726,0.12401455675652,0.215956383317388,"1857"
"R-HSA-3214858~RMTs methylate histone arginines",0.00900900900900901,7.8635694761092,7.57383966244726,0.12401455675652,0.215956383317388,"6601"
"hsa05160_Hepatitis_C",0.0105263157894737,8.03309362840286,7.52620545073375,0.0289012429395612,0.119959953571055,"10971, 208"
"R-HSA-74752~Signaling by Insulin receptor",0.00892857142857143,7.76370048191813,7.47916666666667,0.125484480463784,0.217267414745865,"208"
"R-HSA-8852135~Protein ubiquitination",0.00892857142857143,7.76370048191813,7.47916666666667,0.125484480463784,0.217267414745865,"51322"
"hsa01521_EGFR_tyrosine_kinase_inhibitor_resistance",0.00892857142857143,7.76370048191813,7.47916666666667,0.125484480463784,0.217267414745865,"208"
"GO:0048009~insulin-like growth factor receptor signaling pathway",0.00884955752212389,7.66634778506589,7.38683127572016,0.12695201222807,0.217423283130601,"51232"
"GO:0004725~protein tyrosine phosphatase activity",0.00884955752212389,7.66634778506589,7.38683127572016,0.12695201222807,0.217423283130601,"1845"
"R-HSA-416482~G alpha (12/13) signalling events",0.00884955752212389,7.66634778506589,7.38683127572016,0.12695201222807,0.217423283130601,"10276"
"WP4016:DNA IR damage and cellular response via ATR",0.00884955752212389,7.66634778506589,7.38683127572016,0.12695201222807,0.217423283130601,"6601"
"hsa05161_Hepatitis_B",0.0103092783505155,7.83206994454811,7.34151329243354,0.0302533489464699,0.122223529743738,"10971, 208"
"GO:0000049~tRNA binding",0.0087719298245614,7.57142331213263,7.29674796747967,0.128417155820241,0.217423283130601,"6165"
"WP2261:Glioblastoma signaling",0.0087719298245614,7.57142331213263,7.29674796747967,0.128417155820241,0.217423283130601,"208"
"GO:0180005~RNA polymerase II CTD heptapeptide repeat T4 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0180008~RNA polymerase II CTD heptapeptide repeat S7 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0140791~histone H2AXS140 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:1990439~MAP kinase serine/threonine phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0033192~calmodulin-dependent protein phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0180004~RNA polymerase II CTD heptapeptide repeat Y1 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0180007~RNA polymerase II CTD heptapeptide repeat S5 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"GO:0180006~RNA polymerase II CTD heptapeptide repeat S2 phosphatase activity",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"1845"
"R-HSA-109581~Apoptosis",0.0101522842639594,7.68779576173695,7.20883534136546,0.0312838177640457,0.122620072027742,"10971, 208"
"R-HSA-381340~Transcriptional regulation of white adipocyte differentiation",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"6721"
"WP1544:MicroRNAs in cardiomyocyte hypertrophy",0.00869565217391304,7.47884230941924,7.20883534136546,0.129879915005409,0.217423283130601,"208"
"GO:0030165~PDZ domain binding",0.00862068965517241,7.38852298603644,7.12301587301587,0.131340293542934,0.219061150147756,"51232"
"WP4806:EGFR tyrosine kinase inhibitor resistance",0.00862068965517241,7.38852298603644,7.12301587301587,0.131340293542934,0.219061150147756,"208"
"GO:0051091~positive regulation of DNA-binding transcription factor activity",0.00854700854700855,7.30038629514131,7.03921568627451,0.132798295186445,0.220683090172722,"81603"
"WP2571:Polycystic kidney disease pathway",0.00854700854700855,7.30038629514131,7.03921568627451,0.132798295186445,0.220683090172722,"1857"
"GO:0010508~positive regulation of autophagy",0.00847457627118644,7.21435580627409,6.95736434108527,0.134253923683844,0.221482425823257,"81603"
"GO:0008203~cholesterol metabolic process",0.00847457627118644,7.21435580627409,6.95736434108527,0.134253923683844,0.221482425823257,"6721"
"GO:0017018~myosin phosphatase activity",0.00847457627118644,7.21435580627409,6.95736434108527,0.134253923683844,0.221482425823257,"1845"
"hsa04012_ErbB_signaling_pathway",0.00847457627118644,7.21435580627409,6.95736434108527,0.134253923683844,0.221482425823257,"208"
"hsa04310_Wnt_signaling_pathway",0.00975609756097561,7.32796382042137,6.87739463601533,0.0340991401130553,0.128654310276295,"1488, 1857"
"hsa04662_B_cell_receptor_signaling_pathway",0.00840336134453781,7.13035763518789,6.87739463601533,0.135707182777309,0.223070215451308,"208"
"hsa05210_Colorectal_cancer",0.00840336134453781,7.13035763518789,6.87739463601533,0.135707182777309,0.223070215451308,"208"
"GO:0045444~fat cell differentiation",0.00826446280991736,6.96817523992194,6.72284644194757,0.138606607692617,0.22652665107118,"208"
"WP4263:Pancreatic adenocarcinoma pathway",0.00826446280991736,6.96817523992194,6.72284644194757,0.138606607692617,0.22652665107118,"208"
"GO:0004726~non-membrane spanning protein tyrosine phosphatase activity",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"1845"
"GO:0030946~protein tyrosine phosphatase activity, metal-dependent",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"1845"
"R-HSA-8876198~RAB GEFs exchange GTP for GDP on RABs",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"208"
"WP673:ErbB signaling",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"208"
"hsa04211_Longevity_regulating_pathway",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"208"
"hsa05235_PD-L1_expression_and_PD-1_checkpoint_pathway_in_cancer",0.00819672131147541,6.88695959998504,6.64814814814815,0.1400527809703,0.22652665107118,"208"
"GO:0140793~histone H2AXY142 phosphatase activity",0.00813008130081301,6.81046579529655,6.57509157509157,0.141496599755748,0.228050370882935,"1845"
"KW-0119~Carbohydrate metabolism",0.00813008130081301,6.81046579529655,6.57509157509157,0.141496599755748,0.228050370882935,"208"
"GO:0032869~cellular response to insulin stimulus",0.00806451612903226,6.73567010419144,6.5036231884058,0.142938067762671,0.229154680063964,"208"
"WP3925:Amino acid metabolism",0.00806451612903226,6.73567010419144,6.5036231884058,0.142938067762671,0.229154680063964,"2746"
"WP5355:Metabolic epileptic disorders",0.00806451612903226,6.73567010419144,6.5036231884058,0.142938067762671,0.229154680063964,"2746"
"GO:0006396~RNA processing",0.008,6.66250370977325,6.4336917562724,0.14437718869911,0.230648268062374,"9987"
"hsa05222_Small_cell_lung_cancer",0.008,6.66250370977325,6.4336917562724,0.14437718869911,0.230648268062374,"208"
"GO:0032880~regulation of protein localization",0.00793650793650794,6.59054024616083,6.36524822695035,0.145813966267445,0.232534904100189,"1857"
"R-HSA-877300~Interferon gamma signaling",0.0078740157480315,6.52010658922304,6.29824561403509,0.147248404164406,0.233186061647117,"81603"
"R-HSA-69473~G2/M DNA damage checkpoint",0.0078740157480315,6.52010658922304,6.29824561403509,0.147248404164406,0.233186061647117,"10971"
"WP4658:Small cell lung cancer",0.0078740157480315,6.52010658922304,6.29824561403509,0.147248404164406,0.233186061647117,"208"
"WP75:Toll like receptor signaling",0.0078740157480315,6.52010658922304,6.29824561403509,0.147248404164406,0.233186061647117,"208"
"GO:0051604~protein maturation",0.0078125,6.4511545746709,6.23263888888889,0.148680506081077,0.234229774744712,"10730"
"GO:0042393~histone binding",0.00896860986547085,6.6270173876899,6.23263888888889,0.0407792544887998,0.137965329792732,"5763, 6601"
"R-HSA-5625740~RHO GTPases activate PKNs",0.0078125,6.4511545746709,6.23263888888889,0.148680506081077,0.234229774744712,"10971"
"hsa01522_Endocrine_resistance",0.0078125,6.4511545746709,6.23263888888889,0.148680506081077,0.234229774744712,"208"
"R-HSA-975871~MyD88 cascade initiated on plasma membrane",0.00775193798449612,6.38363806410281,6.16838487972509,0.150110275702906,0.234450585247322,"1845"
"R-HSA-4420097~VEGFA-VEGFR2 Pathway",0.00775193798449612,6.38363806410281,6.16838487972509,0.150110275702906,0.234450585247322,"208"
"R-HSA-1592230~Mitochondrial biogenesis",0.00775193798449612,6.38363806410281,6.16838487972509,0.150110275702906,0.234450585247322,"2746"
"R-HSA-168142~Toll Like Receptor 10 (TLR10) Cascade",0.00775193798449612,6.38363806410281,6.16838487972509,0.150110275702906,0.234450585247322,"1845"
"R-HSA-168176~Toll Like Receptor 5 (TLR5) Cascade",0.00775193798449612,6.38363806410281,6.16838487972509,0.150110275702906,0.234450585247322,"1845"
"GO:0046330~positive regulation of JNK cascade",0.00769230769230769,6.3175128360857,6.10544217687075,0.151537716709716,0.235466298272021,"1857"
"KW-0879~Wnt signaling pathway",0.00881057268722467,6.48907004719803,6.10544217687075,0.0423262690861515,0.139242621678309,"1857, 54994"
"WP5475:Hallmark of cancer sustaining proliferative signaling",0.00769230769230769,6.3175128360857,6.10544217687075,0.151537716709716,0.235466298272021,"208"
"hsa05215_Prostate_cancer",0.00769230769230769,6.3175128360857,6.10544217687075,0.151537716709716,0.235466298272021,"208"
"GO:0042632~cholesterol homeostasis",0.00763358778625954,6.25273648380078,6.04377104377104,0.15296283277571,0.235666466090035,"6721"
"R-HSA-193704~p75 NTR receptor-mediated signalling",0.00763358778625954,6.25273648380078,6.04377104377104,0.15296283277571,0.235666466090035,"10276"
"KW-0931~ER-Golgi transport",0.00763358778625954,6.25273648380078,6.04377104377104,0.15296283277571,0.235666466090035,"8774"
"hsa04666_Fc_gamma_R-mediated_phagocytosis",0.00763358778625954,6.25273648380078,6.04377104377104,0.15296283277571,0.235666466090035,"208"
"hsa05231_Choline_metabolism_in_cancer",0.00763358778625954,6.25273648380078,6.04377104377104,0.15296283277571,0.235666466090035,"208"
"R-HSA-5357801~Programmed Cell Death",0.00869565217391304,6.38928420182384,6.01340033500838,0.0435009785246207,0.139793209817006,"10971, 208"
"R-HSA-9694516~SARS-CoV-2 Infection",0.00911854103343465,6.55768741630876,6.00334448160535,0.0134108490211082,0.0902997167421284,"10971, 208, 6191"
"GO:0016055~Wnt signaling pathway",0.00865800865800866,6.35669400938607,5.98333333333333,0.0438952718188887,0.139793209817006,"1857, 54994"
"R-HSA-9845323~Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)",0.00757575757575758,6.18926831895276,5.98333333333333,0.154385627569479,0.237456066769301,"6601"
"KW-0343~GTPase activation",0.00862068965517241,6.32443128750127,5.95356550580431,0.0442909179618237,0.139793209817006,"23637, 57148"
"WP185:Integrin mediated cell adhesion",0.0075187969924812,6.12708048004623,5.92409240924092,0.155806104754015,0.238430554244781,"208"
"hsa04916_Melanogenesis",0.0075187969924812,6.12708048004623,5.92409240924092,0.155806104754015,0.238430554244781,"1857"
"hsa04933_AGE-RAGE_signaling_pathway_in_diabetic_complications",0.0075187969924812,6.12708048004623,5.92409240924092,0.155806104754015,0.238430554244781,"208"
"GO:0032956~regulation of actin cytoskeleton organization",0.00746268656716418,6.06612588103896,5.86601307189542,0.157224267986714,0.239793388590474,"1857"
"GO:0004867~serine-type endopeptidase inhibitor activity",0.00746268656716418,6.06612588103896,5.86601307189542,0.157224267986714,0.239793388590474,"51232"
"R-HSA-975138~TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.00740740740740741,6.00636716742253,5.80906148867314,0.158640120919384,0.240741018223238,"1845"
"KW-0753~Steroid metabolism",0.00740740740740741,6.00636716742253,5.80906148867314,0.158640120919384,0.240741018223238,"6721"
"hsa05142_Chagas_disease",0.00740740740740741,6.00636716742253,5.80906148867314,0.158640120919384,0.240741018223238,"208"
"R-HSA-975155~MyD88 dependent cascade initiated on endosome",0.00735294117647059,5.9477694186595,5.75320512820513,0.160053667198258,0.242481305805361,"1845"
"R-HSA-428157~Sphingolipid metabolism",0.0072992700729927,5.89029904683911,5.6984126984127,0.161464910464002,0.243806650517903,"9218"
"hsa04625_C-type_lectin_receptor_signaling_pathway",0.0072992700729927,5.89029904683911,5.6984126984127,0.161464910464002,0.243806650517903,"208"
"GO:0060070~canonical Wnt signaling pathway",0.0072463768115942,5.83392373712741,5.64465408805031,0.162873854351714,0.244310781527571,"1857"
"R-HSA-168164~Toll Like Receptor 3 (TLR3) Cascade",0.0072463768115942,5.83392373712741,5.64465408805031,0.162873854351714,0.244310781527571,"1845"
"R-HSA-6811434~COPI-dependent Golgi-to-ER retrograde traffic",0.0072463768115942,5.83392373712741,5.64465408805031,0.162873854351714,0.244310781527571,"8774"
"hsa04922_Glucagon_signaling_pathway",0.0072463768115942,5.83392373712741,5.64465408805031,0.162873854351714,0.244310781527571,"208"
"GO:0045296~cadherin binding",0.00859598853868195,6.13644493545921,5.6269592476489,0.015933345433381,0.0985742559360228,"55082, 6152, 9218"
"R-HSA-195721~Signaling by WNT",0.00857142857142857,6.11677814477679,5.609375,0.0160660384506727,0.0985742559360228,"1488, 1857, 208"
"GO:0030334~regulation of cell migration",0.00719424460431655,5.77861239118769,5.59190031152648,0.164280502490948,0.244804879941429,"208"
"GO:0003697~single-stranded DNA binding",0.00719424460431655,5.77861239118769,5.59190031152648,0.164280502490948,0.244804879941429,"9987"
"R-HSA-6807878~COPI-mediated anterograde transport",0.00719424460431655,5.77861239118769,5.59190031152648,0.164280502490948,0.244804879941429,"8774"
"R-HSA-8878166~Transcriptional regulation by RUNX2",0.00719424460431655,5.77861239118769,5.59190031152648,0.164280502490948,0.244804879941429,"208"
"GO:0051649~establishment of localization in cell",0.00714285714285714,5.72433507333923,5.54012345679012,0.165684858505704,0.245185834879171,"9522"
"R-HSA-194138~Signaling by VEGF",0.00714285714285714,5.72433507333923,5.54012345679012,0.165684858505704,0.245185834879171,"208"
"R-HSA-168181~Toll Like Receptor 7/8 (TLR7/8) Cascade",0.00714285714285714,5.72433507333923,5.54012345679012,0.165684858505704,0.245185834879171,"1845"
"WP4321:Thermogenesis",0.00714285714285714,5.72433507333923,5.54012345679012,0.165684858505704,0.245185834879171,"6601"
"GO:0004222~metalloendopeptidase activity",0.00709219858156028,5.67106295926174,5.48929663608563,0.167086926014454,0.245185834879171,"10730"
"R-HSA-9843745~Adipogenesis",0.00709219858156028,5.67106295926174,5.48929663608563,0.167086926014454,0.245185834879171,"6721"
"WP2263:Androgen receptor network in prostate cancer",0.00709219858156028,5.67106295926174,5.48929663608563,0.167086926014454,0.245185834879171,"6601"
"hsa04620_Toll-like_receptor_signaling_pathway",0.00709219858156028,5.67106295926174,5.48929663608563,0.167086926014454,0.245185834879171,"208"
"hsa04931_Insulin_resistance",0.00709219858156028,5.67106295926174,5.48929663608563,0.167086926014454,0.245185834879171,"208"
"GO:0003690~double-stranded DNA binding",0.00704225352112676,5.61876828708486,5.43939393939394,0.168486708630136,0.245185834879171,"9987"
"GO:0008013~beta-catenin binding",0.00704225352112676,5.61876828708486,5.43939393939394,0.168486708630136,0.245185834879171,"1857"
"hsa04066_HIF-1_signaling_pathway",0.00704225352112676,5.61876828708486,5.43939393939394,0.168486708630136,0.245185834879171,"208"
"WP2005:miR targeted genes in muscle cell",0.00831024930747922,5.90835757598263,5.42296072507553,0.0175672027291774,0.100464435141095,"10971, 8774, 9522"
"GO:0090263~positive regulation of canonical Wnt signaling pathway",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"54994"
"GO:0002020~protease binding",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"1857"
"R-HSA-201681~TCF dependent signaling in response to WNT",0.00790513833992095,5.71478042179275,5.39039039039039,0.0529026954642433,0.152662064053959,"1857, 208"
"R-HSA-166166~MyD88-independent TLR4 cascade ",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"1845"
"R-HSA-168138~Toll Like Receptor 9 (TLR9) Cascade",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"1845"
"R-HSA-937061~TRIF (TICAM1)-mediated TLR4 signaling ",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"1845"
"hsa04914_Progesterone-mediated_oocyte_maturation",0.00699300699300699,5.56742431072689,5.39039039039039,0.169884209960169,0.245185834879171,"208"
"GO:0006260~DNA replication",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"5763"
"GO:0036211~protein modification process",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"208"
"R-HSA-9755511~KEAP1-NFE2L2 pathway",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"208"
"R-HSA-2219528~PI3K/AKT Signaling in Cancer",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"208"
"KW-0469~Meiosis",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"22887"
"hsa05145_Toxoplasmosis",0.00694444444444444,5.51777037299274,5.34226190476191,0.171279433606462,0.245185834879171,"208"
"GO:0007005~mitochondrion organization",0.00689655172413793,5.46826421594101,5.29498525073746,0.172672383165418,0.24601754905543,"10730"
"R-HSA-166058~MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.00689655172413793,5.46826421594101,5.29498525073746,0.172672383165418,0.24601754905543,"1845"
"R-HSA-168188~Toll Like Receptor TLR6:TLR2 Cascade",0.00689655172413793,5.46826421594101,5.29498525073746,0.172672383165418,0.24601754905543,"1845"
"R-HSA-187037~Signaling by NTRK1 (TRKA)",0.00684931506849315,5.41963133033266,5.24853801169591,0.174063062227946,0.247610835000317,"1845"
"GO:0043123~positive regulation of canonical NF-kappaB signal transduction",0.00766283524904215,5.51277787248109,5.20289855072464,0.0563296568618325,0.156586110359039,"81603, 9218"
"hsa04725_Cholinergic_synapse",0.00680272108843537,5.37184851954003,5.20289855072464,0.175451474379465,0.249195922204584,"208"
"GO:0042593~glucose homeostasis",0.00675675675675676,5.32489342054235,5.15804597701149,0.176837623199917,0.249604657591188,"23637"
"R-HSA-168179~Toll Like Receptor TLR1:TLR2 Cascade",0.00675675675675676,5.32489342054235,5.15804597701149,0.176837623199917,0.249604657591188,"1845"
"R-HSA-181438~Toll Like Receptor 2 (TLR2) Cascade",0.00675675675675676,5.32489342054235,5.15804597701149,0.176837623199917,0.249604657591188,"1845"
"hsa01200_Carbon_metabolism",0.00675675675675676,5.32489342054235,5.15804597701149,0.176837623199917,0.249604657591188,"2746"
"R-HSA-1989781~PPARA activates gene expression",0.00671140939597315,5.27874446949163,5.11396011396011,0.178221512263772,0.250391583690523,"6721"
"hsa03082_ATP-dependent_chromatin_remodeling",0.00671140939597315,5.27874446949163,5.11396011396011,0.178221512263772,0.250391583690523,"6601"
"R-HSA-400206~Regulation of lipid metabolism by PPARalpha",0.00666666666666667,5.23338086873851,5.07062146892655,0.179603145140035,0.251943300821438,"6721"
"GO:0051092~positive regulation of NF-kappaB transcription factor activity",0.00662251655629139,5.18878255524786,5.02801120448179,0.180982525392257,0.252690438765087,"81603"
"GO:0006887~exocytosis",0.00662251655629139,5.18878255524786,5.02801120448179,0.180982525392257,0.252690438765087,"9522"
"hsa04014_Ras_signaling_pathway",0.00743494423791822,5.32371876840751,5.02801120448179,0.0598333544955425,0.157806147077104,"208, 57148"
"hsa04668_TNF_signaling_pathway",0.00662251655629139,5.18878255524786,5.02801120448179,0.180982525392257,0.252690438765087,"208"
"GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport",0.00657894736842105,5.14482277122718,4.98611111111111,0.182359656578544,0.252690438765087,"9218"
"R-HSA-199418~Negative regulation of the PI3K/AKT network",0.00657894736842105,5.14482277122718,4.98611111111111,0.182359656578544,0.252690438765087,"208"
"WP179:Cell cycle",0.00657894736842105,5.14482277122718,4.98611111111111,0.182359656578544,0.252690438765087,"10971"
"hsa04722_Neurotrophin_signaling_pathway",0.00657894736842105,5.14482277122718,4.98611111111111,0.182359656578544,0.252690438765087,"208"
"GO:0007264~small GTPase-mediated signal transduction",0.0065359477124183,5.1015422031136,4.94490358126722,0.183734542251559,0.253026213588434,"10971"
"R-HSA-69206~G1/S Transition",0.0065359477124183,5.1015422031136,4.94490358126722,0.183734542251559,0.253026213588434,"208"
"WP2006:miR targeted genes in squamous cell",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"10971"
"WP4549:Fragile X syndrome",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"1845"
"hsa04071_Sphingolipid_signaling_pathway",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"208"
"hsa04152_AMPK_signaling_pathway",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"208"
"hsa04660_T_cell_receptor_signaling_pathway",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"208"
"hsa04919_Thyroid_hormone_signaling_pathway",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"208"
"hsa04935_Growth_hormone_synthesis,_secretion_and_action",0.00649350649350649,5.05864205033314,4.90437158469945,0.185107185958535,0.253026213588434,"208"
"WP382:MAPK signaling",0.00719424460431655,5.1244589225239,4.84480431848853,0.0638636203424913,0.16125564136479,"1845, 208"
"GO:0001934~positive regulation of protein phosphorylation",0.00641025641025641,4.97648797279888,4.8252688172043,0.187845761636199,0.256384080071028,"1857"
"hsa04611_Platelet_activation",0.00632911392405063,4.89533566506668,4.74867724867725,0.190575411881087,0.259719714242741,"208"
"GO:0000166~nucleotide binding",0.00628930817610063,4.85638163264266,4.71128608923885,0.191936898776847,0.260793185333564,"2746"
"WP2003:miR targeted genes in leukocytes",0.00628930817610063,4.85638163264266,4.71128608923885,0.191936898776847,0.260793185333564,"10971"
"GO:0031175~neuron projection development",0.00625,4.81800430115686,4.67447916666667,0.193296164876367,0.261310108213796,"9218"
"R-HSA-6807070~PTEN Regulation",0.00625,4.81800430115686,4.67447916666667,0.193296164876367,0.261310108213796,"208"
"R-HSA-1630316~Glycosaminoglycan metabolism",0.00625,4.81800430115686,4.67447916666667,0.193296164876367,0.261310108213796,"3423"
"R-HSA-199991~Membrane Trafficking",0.00741839762611276,5.31179647841374,4.63106295149639,0.00409964771855205,0.0610914717403904,"10971, 208, 23637, 57148, 8774"
"R-HSA-1428517~Aerobic respiration and respiratory electron transport",0.00689655172413793,4.88288941457964,4.62033462033462,0.069377426381372,0.166622768612141,"54994, 64795"
"hsa04926_Relaxin_signaling_pathway",0.00617283950617284,4.74296031927744,4.6025641025641,0.196008048719073,0.263957505608352,"208"
"WP2059:Alzheimer 39 s disease and miRNA effects",0.00680272108843537,4.80713647128406,4.55006337135615,0.0712496989168197,0.168223315104907,"1857, 208"
"WP5124:Alzheimer 39 s disease",0.00680272108843537,4.80713647128406,4.55006337135615,0.0712496989168197,0.168223315104907,"1857, 208"
"R-HSA-3858494~Beta-catenin independent WNT signaling",0.00609756097560976,4.67014798904363,4.53282828282828,0.198711091420367,0.266339480629577,"1857"
"hsa04728_Dopaminergic_synapse",0.00609756097560976,4.67014798904363,4.53282828282828,0.198711091420367,0.266339480629577,"208"
"R-HSA-166520~Signaling by NTRKs",0.00606060606060606,4.63455624097805,4.49874686716792,0.200059306073053,0.266647960733732,"1845"
"hsa04068_FoxO_signaling_pathway",0.00606060606060606,4.63455624097805,4.49874686716792,0.200059306073053,0.266647960733732,"208"
"hsa04142_Lysosome",0.00606060606060606,4.63455624097805,4.49874686716792,0.200059306073053,0.266647960733732,"3423"
"KW-0810~Translation regulation",0.00602409638554217,4.59948025267552,4.46517412935323,0.201405320905788,0.268048955641817,"208"
"WP2004:miR targeted genes in lymphocytes",0.00681818181818182,4.74276259975334,4.3780487804878,0.0306058049823183,0.122620072027742,"10971, 8774, 9522"
"GO:0006364~rRNA processing",0.00591715976331361,4.49784810854484,4.36739659367397,0.205430201231247,0.272209989678139,"6165"
"hsa04210_Apoptosis",0.00591715976331361,4.49784810854484,4.36739659367397,0.205430201231247,0.272209989678139,"208"
"R-HSA-5653656~Vesicle-mediated transport",0.00700280112044818,4.98941671373345,4.36103012633625,0.00528422351704217,0.0649102591485316,"10971, 208, 23637, 57148, 8774"
"R-HSA-453279~Mitotic G1 phase and G1/S transition",0.00588235294117647,4.46465543854459,4.33574879227053,0.206767451504573,0.272393642634285,"208"
"hsa04380_Osteoclast_differentiation",0.00588235294117647,4.46465543854459,4.33574879227053,0.206767451504573,0.272393642634285,"208"
"hsa04910_Insulin_signaling_pathway",0.00588235294117647,4.46465543854459,4.33574879227053,0.206767451504573,0.272393642634285,"208"
"hsa05135_Yersinia_infection",0.00588235294117647,4.46465543854459,4.33574879227053,0.206767451504573,0.272393642634285,"208"
"hsa04114_Oocyte_meiosis",0.00584795321637427,4.43198116860878,4.30455635491607,0.208102519291605,0.272572319936699,"10971"
"hsa04371_Apelin_signaling_pathway",0.00584795321637427,4.43198116860878,4.30455635491607,0.208102519291605,0.272572319936699,"208"
"hsa04915_Estrogen_signaling_pathway",0.00584795321637427,4.43198116860878,4.30455635491607,0.208102519291605,0.272572319936699,"208"
"hsa05162_Measles",0.00584795321637427,4.43198116860878,4.30455635491607,0.208102519291605,0.272572319936699,"208"
"R-HSA-9679506~SARS-CoV Infections",0.0066815144766147,4.63777899783077,4.28400954653938,0.0323432004269247,0.12564089396613,"10971, 208, 6191"
"GO:0005096~GTPase activator activity",0.00643086816720257,4.50944814649954,4.27380952380952,0.079389441431453,0.176801853836341,"23637, 57148"
"R-HSA-8856688~Golgi-to-ER retrograde transport",0.00581395348837209,4.39980571348117,4.27380952380952,0.20943540804318,0.273529864815015,"8774"
"hsa05418_Fluid_shear_stress_and_atherosclerosis",0.00581395348837209,4.39980571348117,4.27380952380952,0.20943540804318,0.273529864815015,"208"
"GO:0044325~transmembrane transporter binding",0.00574712643678161,4.3368831066214,4.21361502347418,0.212094662216902,0.275814088633998,"10971"
"R-HSA-5663220~RHO GTPases Activate Formins",0.00574712643678161,4.3368831066214,4.21361502347418,0.212094662216902,0.275814088633998,"1857"
"R-HSA-9675108~Nervous system development",0.00668896321070234,4.6730022991007,4.20620972466315,0.0144021591133059,0.0943379363472736,"6152, 6165, 6191, 6721"
"GO:0045893~positive regulation of DNA-templated transcription",0.0067476383265857,4.79202158888454,4.19588592800374,0.00621058357697195,0.0704897914761965,"1857, 51322, 55082, 6601, 81603"
"GO:0045892~negative regulation of DNA-templated transcription",0.00666666666666667,4.65613074111028,4.19147694103911,0.0145721976279606,0.0943379363472736,"10971, 1112, 1488, 6601"
"KW-0904~Protein phosphatase",0.00571428571428571,4.30610610894906,4.18414918414918,0.213421034514349,0.27635287802499,"1845"
"hsa04936_Alcoholic_liver_disease",0.00571428571428571,4.30610610894906,4.18414918414918,0.213421034514349,0.27635287802499,"208"
"hsa05017_Spinocerebellar_ataxia",0.00571428571428571,4.30610610894906,4.18414918414918,0.213421034514349,0.27635287802499,"208"
"GO:0030336~negative regulation of cell migration",0.00568181818181818,4.27576774715408,4.15509259259259,0.214745241526951,0.277672012159315,"1845"
"R-HSA-9842860~Regulation of endogenous retroelements",0.00561797752808989,4.21636095010306,4.09817351598173,0.217387173390422,0.280290695903396,"6601"
"WP2857:Mesodermal commitment pathway",0.00561797752808989,4.21636095010306,4.09817351598173,0.217387173390422,0.280290695903396,"1488"
"WP5087:Pleural mesothelioma",0.00639658848614072,4.42033582255234,4.08883826879271,0.0363873820140118,0.131777411357517,"1488, 1857, 208"
"GO:0031267~small GTPase binding",0.00617283950617284,4.30498913118846,4.08418657565415,0.0858036235835843,0.181807677942839,"1857, 23637"
"GO:0000209~protein polyubiquitination",0.00558659217877095,4.18727176422221,4.0702947845805,0.218704905074596,0.281192020810195,"64795"
"R-HSA-166016~Toll Like Receptor 4 (TLR4) Cascade",0.00558659217877095,4.18727176422221,4.0702947845805,0.218704905074596,0.281192020810195,"1845"
"KW-0648~Protein biosynthesis",0.00552486187845304,4.12997601054907,4.01565995525727,0.221333916991871,0.283769436594655,"1615"
"hsa04072_Phospholipase_D_signaling_pathway",0.00552486187845304,4.12997601054907,4.01565995525727,0.221333916991871,0.283769436594655,"208"
"R-HSA-8980692~RHOA GTPase cycle",0.00549450549450549,4.1023345187054,3.98888888888889,0.222645204026943,0.284647665907864,"10276"
"R-HSA-69242~S Phase",0.00549450549450549,4.1023345187054,3.98888888888889,0.222645204026943,0.284647665907864,"208"
"hsa04010_MAPK_signaling_pathway",0.00604229607250755,4.20241084510054,3.98888888888889,0.0893217760560338,0.185820717739932,"1845, 208"
"WP536:Calcium regulation in cardiac cells",0.00543478260869565,4.04715559620639,3.93640350877193,0.225261357215849,0.286437695685224,"10971"
"GO:0072659~protein localization to plasma membrane",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"208"
"GO:0140584~chromatin extrusion motor activity",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"10730"
"GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"10730"
"GO:0140849~ATP-dependent H2AZ histone chaperone activity",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"10730"
"R-HSA-8957322~Metabolism of steroids",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"6721"
"hsa04261_Adrenergic_signaling_in_cardiomyocytes",0.00540540540540541,4.02078338339841,3.91067538126362,0.226566230140458,0.286437695685224,"208"
"GO:0008283~cell population proliferation",0.00537634408602151,3.99430540382335,3.88528138528139,0.227868971790385,0.286887666700083,"10730"
"KW-0482~Metalloprotease",0.00537634408602151,3.99430540382335,3.88528138528139,0.227868971790385,0.286887666700083,"10730"
"WP4396:Nonalcoholic fatty liver disease",0.00537634408602151,3.99430540382335,3.88528138528139,0.227868971790385,0.286887666700083,"208"
"GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process",0.00586510263929619,4.06391900324405,3.86021505376344,0.0944223024230633,0.189791418988424,"54994, 64795"
"GO:0061775~cohesin loader activity",0.0053475935828877,3.96817200717423,3.86021505376344,0.229169585538071,0.287331245867733,"10730"
"R-HSA-69481~G2/M Checkpoints",0.0053475935828877,3.96817200717423,3.86021505376344,0.229169585538071,0.287331245867733,"10971"
"hsa04934_Cushing_syndrome",0.0053475935828877,3.96817200717423,3.86021505376344,0.229169585538071,0.287331245867733,"1857"
"GO:0035556~intracellular signal transduction",0.00604838709677419,4.1568375998022,3.8519313304721,0.0422448123887235,0.139242621678309,"10276, 1857, 208"
"R-HSA-73887~Death Receptor Signaling",0.00531914893617021,3.94237689086919,3.83547008547009,0.230468074750793,0.287373772220125,"10276"
"WP289:Myometrial relaxation and contraction pathways",0.00531914893617021,3.94237689086919,3.83547008547009,0.230468074750793,0.287373772220125,"10971"
"WP5381:Smith Magenis and Potocki Lupski syndrome copy number variation",0.00531914893617021,3.94237689086919,3.83547008547009,0.230468074750793,0.287373772220125,"64795"
"hsa04932_Non-alcoholic_fatty_liver_disease",0.00531914893617021,3.94237689086919,3.83547008547009,0.230468074750793,0.287373772220125,"208"
"WP706:Sudden infant death syndrome SIDS susceptibility pathways",0.00529100529100529,3.91691393836809,3.81104033970276,0.231764442790674,0.288199560187036,"10971"
"hsa04218_Cellular_senescence",0.00529100529100529,3.91691393836809,3.81104033970276,0.231764442790674,0.288199560187036,"208"
"KW-0156~Chromatin regulator",0.00576368876080692,3.98505783631041,3.78691983122363,0.0975232361135179,0.192296359278065,"51322, 6601"
"KW-0436~Ligase",0.00526315789473684,3.89177719727734,3.78691983122363,0.233058693014685,0.289018215484786,"1615"
"hsa04110_Cell_cycle",0.00526315789473684,3.89177719727734,3.78691983122363,0.233058693014685,0.289018215484786,"10971"
"hsa04217_Necroptosis",0.00523560209424084,3.86696086134433,3.76310272536688,0.234350828774654,0.29022466397297,"2746"
"WP481:Insulin signaling",0.00520833333333333,3.84245925573237,3.73958333333333,0.235640853417278,0.291425218716062,"208"
"GO:0008104~protein localization",0.00518134715025907,3.81826682505344,3.71635610766046,0.236928770284126,0.291826899984107,"10971"
"R-HSA-2262752~Cellular responses to stress",0.00600240096038415,4.22084864892114,3.71635610766046,0.0102316500287857,0.0837889178032994,"10730, 208, 6152, 6165, 6191"
"R-HSA-5633007~Regulation of TP53 Activity",0.00518134715025907,3.81826682505344,3.71635610766046,0.236928770284126,0.291826899984107,"208"
"WP4239:Epithelial to mesenchymal transition in colorectal cancer",0.00518134715025907,3.81826682505344,3.71635610766046,0.236928770284126,0.291826899984107,"208"
"GO:0003689~DNA clamp loader activity",0.00515463917525773,3.79437812371053,3.69341563786008,0.23821458271165,0.292354468353571,"10730"
"R-HSA-199977~ER to Golgi Anterograde Transport",0.00515463917525773,3.79437812371053,3.69341563786008,0.23821458271165,0.292354468353571,"8774"
"R-HSA-9658195~Leishmania infection",0.0050761421319797,3.72448143512991,3.62626262626263,0.242059426646154,0.29574196078139,"1857"
"R-HSA-9824443~Parasitic Infection Pathways",0.0050761421319797,3.72448143512991,3.62626262626263,0.242059426646154,0.29574196078139,"1857"
"WP3929:Chemokine signaling",0.0050761421319797,3.72448143512991,3.62626262626263,0.242059426646154,0.29574196078139,"208"
"R-HSA-195258~RHO GTPase Effectors",0.00552486187845304,3.8005782633916,3.61530715005035,0.105402348393587,0.201283056070946,"10971, 1857"
"R-HSA-9824446~Viral Infection Pathways",0.0058343057176196,4.09279739397768,3.60876558102131,0.0115219787249265,0.0882373726706501,"10971, 208, 6152, 6165, 6191"
"GO:0140297~DNA-binding transcription factor binding",0.00505050505050505,3.70175515200749,3.60441767068273,0.243336854578774,0.296108702559712,"1488"
"R-HSA-9609507~Protein localization",0.00505050505050505,3.70175515200749,3.60441767068273,0.243336854578774,0.296108702559712,"9218"
"hsa04022_cGMP-PKG_signaling_pathway",0.00505050505050505,3.70175515200749,3.60441767068273,0.243336854578774,0.296108702559712,"208"
"hsa05165_Human_papillomavirus_infection",0.00550964187327824,3.78888223323238,3.60441767068273,0.105933832586004,0.201873907380876,"1857, 208"
"hsa04140_Autophagy",0.005,3.65713146735001,3.56150793650794,0.24588545024914,0.298013165701958,"208"
"hsa04630_JAK-STAT_signaling_pathway",0.005,3.65713146735001,3.56150793650794,0.24588545024914,0.298013165701958,"208"
"GO:0043565~sequence-specific DNA binding",0.00543478260869565,3.73146301774517,3.55093966369931,0.108602493797577,0.20463357227179,"1112, 22887"
"KW-0344~Guanine-nucleotide releasing factor",0.00497512437810945,3.63522434211102,3.54043392504931,0.247156624593614,0.29915495573315,"10276"
"WP5434:Cancer pathways",0.00556586270871985,3.79538852698393,3.52652259332024,0.0524999064205248,0.151982213172793,"1488, 1857, 208"
"GO:0006338~chromatin remodeling",0.00564174894217207,3.88380546596346,3.51960784313725,0.0258552015400274,0.117716681426429,"1845, 208, 51322, 6601"
"R-HSA-5663205~Infectious disease",0.00571428571428571,4.08462101191087,3.50928641251222,0.00634147675972579,0.0704897914761965,"10971, 1857, 208, 6152, 6165, 6191"
"R-HSA-168898~Toll-like Receptor Cascades",0.00490196078431373,3.57028698558708,3.47868217054264,0.250957693198337,0.303351786060223,"1845"
"hsa05164_Influenza_A",0.0048780487804878,3.54941511769069,3.45857418111753,0.25222057554261,0.304473443782513,"208"
"GO:0061630~ubiquitin protein ligase activity",0.00523560209424084,3.57877602875401,3.40930674264008,0.116171077585532,0.208694682856223,"64795, 81603"
"hsa05200_Pathways_in_cancer",0.00533807829181495,3.62560646214419,3.37406015037594,0.0584412869259846,0.157768410271465,"1488, 1857, 208"
"R-HSA-3700989~Transcriptional Regulation by TP53",0.0051150895140665,3.48740411426685,3.32407407407407,0.121108000050402,0.212934568753995,"10971, 208"
"hsa04151_PI3K-Akt_signaling_pathway",0.00508905852417303,3.46767286658309,3.30570902394107,0.122212351466748,0.214048222511125,"10971, 208"
"hsa05152_Tuberculosis",0.00469483568075117,3.39055402035353,3.30570902394107,0.262249575651968,0.315741542076342,"208"
"R-HSA-422475~Axon guidance",0.00522648083623693,3.5431860819079,3.29963235294118,0.0616642770667317,0.157895289728617,"6152, 6165, 6191"
"hsa05168_Herpes_simplex_virus_1_infection",0.00467289719626168,3.37164995069969,3.28754578754579,0.263493992131393,0.316401636522373,"208"
"KW-0694~RNA-binding",0.00527704485488127,3.61178746046681,3.2830361225423,0.0322780375046442,0.12564089396613,"55082, 6165, 6191, 9987"
"R-HSA-8953897~Cellular responses to stimuli",0.00529661016949153,3.68472761330445,3.26601164483261,0.0171356924433534,0.0992123849108804,"10730, 208, 6152, 6165, 6191"
"GO:0046983~protein dimerization activity",0.00462962962962963,3.33446109603253,3.2518115942029,0.265976721687036,0.318541291190403,"6721"
"WP4223:Ras signaling",0.00462962962962963,3.33446109603253,3.2518115942029,0.265976721687036,0.318541291190403,"208"
"GO:0042803~protein homodimerization activity",0.00515463917525773,3.52099353066789,3.20392681838465,0.0348555788448746,0.129321310897922,"2746, 54994, 81603, 9218"
"GO:0046982~protein heterodimerization activity",0.00493827160493827,3.35373785167235,3.19964349376114,0.128891609554945,0.217423283130601,"57148, 9218"
"R-HSA-948021~Transport to the Golgi and subsequent modification",0.00444444444444444,3.17669207487386,3.10017271157168,0.277048934787003,0.329630211677206,"8774"
"hsa04062_Chemokine_signaling_pathway",0.00444444444444444,3.17669207487386,3.10017271157168,0.277048934787003,0.329630211677206,"208"
"hsa04613_Neutrophil_extracellular_trap_formation",0.00444444444444444,3.17669207487386,3.10017271157168,0.277048934787003,0.329630211677206,"208"
"GO:0006897~endocytosis",0.00440528634361234,3.14361911984388,3.06837606837607,0.27948734118277,0.331663176416629,"9522"
"hsa05010_Alzheimer_disease",0.00475059382422803,3.21278128583393,3.06837606837607,0.137931319362669,0.226316912095065,"1857, 208"
"hsa05167_Kaposi_sarcoma-associated_herpesvirus_infection",0.00440528634361234,3.14361911984388,3.06837606837607,0.27948734118277,0.331663176416629,"208"
"R-HSA-9711123~Cellular response to chemical stress",0.00436681222707424,3.111220914253,3.03722504230118,0.281917771604819,0.334111153049257,"208"
"R-HSA-1280215~Cytokine Signaling in Immune system",0.0048661800486618,3.30768742243864,3.01807482135351,0.0419821299850417,0.139242621678309,"1845, 208, 81603, 9987"
"WP306:Focal adhesion",0.00432900432900433,3.07947710435685,3.00670016750419,0.284340251329683,0.336105706708298,"208"
"hsa05207_Chemical_carcinogenesis",0.00431034482758621,3.06384446116526,2.99166666666667,0.28554851755838,0.337095587611127,"208"
"hsa05205_Proteoglycans_in_cancer",0.00429184549356223,3.04837351226519,2.97678275290216,0.286754805556362,0.338080568418591,"208"
"hsa04510_Focal_adhesion",0.00425531914893617,3.01788726551285,2.94745484400657,0.289161459406566,0.340035920569946,"208"
"hsa05169_Epstein-Barr_virus_infection",0.00423728813559322,3.00286958332863,2.93300653594771,0.290361831519941,0.340127454705704,"208"
"hsa05415_Diabetic_cardiomyopathy",0.00423728813559322,3.00286958332863,2.93300653594771,0.290361831519941,0.340127454705704,"208"
"hsa05203_Viral_carcinogenesis",0.00421940928270042,2.9879992404433,2.91869918699187,0.291560237924928,0.341091706916035,"10971"
"GO:0003714~transcription corepressor activity",0.00418410041841004,2.9586919638792,2.89049919484702,0.293951166079246,0.343446799442204,"1488"
"R-HSA-1266738~Developmental Biology",0.00472334682860999,3.39298824313282,2.87660256410256,0.00912599194268003,0.0821339274841202,"1615, 208, 6152, 6165, 6191, 6601, 6721"
"KW-0678~Repressor",0.00453857791225416,3.03852564322405,2.84469096671949,0.0874394280024178,0.183562217215237,"1112, 1488, 9987"
"R-HSA-6811442~Intra-Golgi and retrograde Golgi-to-ER traffic",0.00411522633744856,2.901753067875,2.83570300157978,0.298709570784113,0.348558408013811,"8774"
"hsa04015_Rap1_signaling_pathway",0.00409836065573771,2.88785581622385,2.82232704402516,0.29989430428284,0.349492208452695,"208"
"hsa05170_Human_immunodeficiency_virus_1_infection",0.00408163265306122,2.87408971868872,2.80907668231612,0.301077096888106,0.350421358606004,"208"
"GO:0008380~RNA splicing",0.0040650406504065,2.86045292092827,2.79595015576324,0.30225795168038,0.351345879894457,"55082"
"hsa05417_Lipid_and_atherosclerosis",0.00403225806451613,2.83355998038685,2.77006172839506,0.304613860124171,0.353632182443003,"208"
"GO:0010468~regulation of gene expression",0.004,2.80716284125529,2.74464831804281,0.306962054163446,0.355903708207363,"9987"
"R-HSA-1430728~Metabolism",0.00452693526482571,3.50348598251447,2.73711497407746,0.00227761947642554,0.0483724375270616,"1615, 2746, 3423, 54994, 6152, 6165, 6191, 64795, 6721, 9218"
"GO:0016491~oxidoreductase activity",0.00396825396825397,2.78124787021354,2.71969696969697,0.309302558272075,0.358160541999128,"2746"
"GO:0007399~nervous system development",0.00420168067226891,2.80595806782489,2.68913857677903,0.169998097351896,0.245185834879171,"51232, 6601"
"R-HSA-8939211~ESR-mediated signaling",0.00392156862745098,2.7431788531975,2.6831091180867,0.312798949166757,0.361748403043998,"208"
"hsa05166_Human_T-cell_leukemia_virus_1_infection",0.00390625,2.73074788393959,2.67113095238095,0.313960594217341,0.362630470322189,"208"
"hsa04024_cAMP_signaling_pathway",0.00387596899224806,2.70621633362302,2.64749262536873,0.316278174626872,0.363920076880793,"208"
"hsa05163_Human_cytomegalovirus_infection",0.00387596899224806,2.70621633362302,2.64749262536873,0.316278174626872,0.363920076880793,"208"
"hsa05208_Chemical_carcinogenesis",0.00387596899224806,2.70621633362302,2.64749262536873,0.316278174626872,0.363920076880793,"208"
"R-HSA-8878171~Transcriptional regulation by RUNX1",0.00386100386100386,2.69411279967596,2.63582966226138,0.31743411602947,0.364327792261096,"6601"
"R-HSA-5663202~Diseases of signal transduction by growth factor receptors and second messengers",0.00408997955010225,2.72404582189074,2.61280931586608,0.17776456991008,0.250391583690523,"1488, 208"
"R-HSA-1643685~Disease",0.00426439232409382,3.10251079968358,2.58598955519539,0.00967751401288483,0.0825314866648407,"10971, 1488, 1857, 208, 3423, 6152, 6165, 6191"
"hsa04810_Regulation_of_actin_cytoskeleton",0.00378787878787879,2.63516085990649,2.57902298850575,0.323185455476352,0.369529030223904,"208"
"R-HSA-449147~Signaling by Interleukins",0.00403225806451613,2.68190960655856,2.57347670250896,0.181971134672336,0.252690438765087,"1845, 9987"
"GO:0004842~ubiquitin-protein transferase activity",0.00377358490566038,2.62367409716664,2.56795422031474,0.324330070859392,0.369907194995217,"64795"
"hsa04714_Thermogenesis",0.00377358490566038,2.62367409716664,2.56795422031474,0.324330070859392,0.369907194995217,"6601"
"GO:0005085~guanyl-nucleotide exchange factor activity",0.0037593984962406,2.6122854824605,2.55698005698006,0.325472809054434,0.370745342644712,"10276"
"GO:0051726~regulation of cell cycle",0.00373134328358209,2.58979766013954,2.53531073446328,0.32775266580619,0.372875060347718,"208"
"R-HSA-8953854~Metabolism of RNA",0.00402684563758389,2.66832269957771,2.51048951048951,0.116005945629525,0.208694682856223,"6152, 6165, 6191"
"R-HSA-194315~Signaling by Rho GTPases",0.00402684563758389,2.66832269957771,2.51048951048951,0.116005945629525,0.208694682856223,"10276, 10971, 1857"
"GO:0045944~positive regulation of transcription by RNA polymerase II",0.00409836065573771,2.78667450440683,2.50978747203579,0.0462190127470647,0.142621486469948,"1488, 1857, 22887, 5763, 6721"
"GO:0006366~transcription by RNA polymerase II",0.00366300366300366,2.53508187939455,2.48271092669433,0.333419665114184,0.377252228790674,"6601"
"GO:0003723~RNA binding",0.004062288422478,2.81090614062622,2.47586206896552,0.0310219525215556,0.122620072027742,"1615, 6152, 6165, 6191, 64397, 9987"
"GO:0003682~chromatin binding",0.00388349514563107,2.57375226233147,2.47245179063361,0.193467219832656,0.261310108213796,"51322, 6601"
"R-HSA-9716542~Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.00394218134034166,2.60749116584259,2.45554035567715,0.12181517345985,0.213764464623559,"10276, 10971, 1857"
"R-HSA-6798695~Neutrophil degranulation",0.00385356454720617,2.5520420826327,2.45218579234973,0.195900828964155,0.263957505608352,"9218, 9522"
"GO:0006325~chromatin organization",0.0036101083032491,2.49315278041679,2.4421768707483,0.337919884535121,0.377252228790674,"51322"
"GO:0019901~protein kinase binding",0.00383141762452107,2.53599217283556,2.43720298710115,0.197728859105108,0.265880965867668,"1488, 1845"
"GO:0003729~mRNA binding",0.00359712230215827,2.48285096976557,2.43224932249323,0.339040327807446,0.377252228790674,"6152"
"GO:0008284~positive regulation of cell population proliferation",0.00381679389312977,2.52541707292214,2.42731575388776,0.198948852967528,0.266339480629577,"54994, 6191"
"GO:0004711~ribosomal protein S6 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0044022~histone H3S28 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0044023~histone H4S1 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0004676~3-phosphoinositide-dependent protein kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0072371~histone H2AS121 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0072354~histone H3T3 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0044024~histone H2AS1 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:1990244~histone H2AT120 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0140855~histone H3S57 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0035175~histone H3S10 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0072518~Rho-dependent protein serine/threonine kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0035979~histone H2AXS139 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0140823~histone H2BS36 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0044025~histone H2BS14 kinase activity",0.003584229390681,2.47263277001177,2.42240215924426,0.340158932309336,0.377252228790674,"208"
"GO:0004677~DNA-dependent protein kinase activity",0.00357142857142857,2.46249719397689,2.41263440860215,0.341275700964264,0.377252228790674,"208"
"GO:0140857~histone H3T45 kinase activity",0.00357142857142857,2.46249719397689,2.41263440860215,0.341275700964264,0.377252228790674,"208"
"hsa05131_Shigellosis",0.00357142857142857,2.46249719397689,2.41263440860215,0.341275700964264,0.377252228790674,"208"
"GO:0035403~histone H3T6 kinase activity",0.00355871886120996,2.45246707729734,2.40294511378849,0.342390636691206,0.377252228790674,"208"
"GO:0035402~histone H3T11 kinase activity",0.00355871886120996,2.45246707729734,2.40294511378849,0.342390636691206,0.377252228790674,"208"
"GO:0043066~negative regulation of apoptotic process",0.00377358490566038,2.49429093442438,2.39812959251837,0.202614892011134,0.269264527541112,"10730, 5763"
"GO:0004679~AMP-activated protein kinase activity",0.00354609929078014,2.44254397317179,2.39333333333333,0.343503742404644,0.378020462283077,"208"
"GO:0016192~vesicle-mediated transport",0.00353356890459364,2.4326929814943,2.38379814077025,0.344615021014577,0.378327360026873,"8774"
"hsa05132_Salmonella_infection",0.00353356890459364,2.4326929814943,2.38379814077025,0.344615021014577,0.378327360026873,"208"
"GO:0009410~response to xenobiotic stimulus",0.00350877192982456,2.41285215881971,2.36495388669302,0.346832108541537,0.380302034576909,"1857"
"GO:0006629~lipid metabolic process",0.00346020761245675,2.37475447912353,2.32814526588846,0.351244485897054,0.384213282407246,"6721"
"R-HSA-1257604~PIP3 activates AKT signaling",0.00337837837837838,2.31078441589289,2.26641414141414,0.358896692452542,0.392111891153078,"208"
"R-HSA-9006934~Signaling by Receptor Tyrosine Kinases",0.00353982300884956,2.32581817864759,2.24094881398252,0.224156712691941,0.286177600894627,"1845, 208"
"R-HSA-5668914~Diseases of metabolism",0.00334448160535117,2.28438320158832,2.24094881398252,0.36214934997484,0.394947461657578,"3423"
"R-HSA-392499~Metabolism of proteins",0.00369685767097967,2.63985210011753,2.23780582826866,0.0218944829326436,0.11056713880985,"10730, 1615, 2746, 51322, 6152, 6165, 6191, 8774"
"GO:0006397~mRNA processing",0.00333333333333333,2.27571353580909,2.23258706467662,0.363230008741183,0.394947461657578,"55082"
"GO:0030335~positive regulation of cell migration",0.00333333333333333,2.27571353580909,2.23258706467662,0.363230008741183,0.394947461657578,"208"
"GO:0003676~nucleic acid binding",0.00332225913621262,2.26710816360331,2.22428748451053,0.364308892024622,0.395647291338568,"1615"
"GO:0001227~DNA-binding transcription repressor activity, RNA polymerase II-specific",0.00328947368421053,2.24164703734872,2.19975490196078,0.367534917216162,0.398447210605345,"6721"
"GO:0008017~microtubule binding",0.00326797385620915,2.22491672732923,2.18369829683698,0.369676774957452,0.399092860375681,"9218"
"R-HSA-3247509~Chromatin modifying enzymes",0.00326797385620915,2.22491672732923,2.18369829683698,0.369676774957452,0.399092860375681,"6601"
"R-HSA-4839726~Chromatin organization",0.00326797385620915,2.22491672732923,2.18369829683698,0.369676774957452,0.399092860375681,"6601"
"GO:0006886~intracellular protein transport",0.00325732899022801,2.21665157243257,2.17575757575758,0.370745064538182,0.399771368523378,"8774"
"R-HSA-69620~Cell Cycle Checkpoints",0.0032258064516129,2.19253355783306,2.15227817745803,0.373939409708005,0.402607729890456,"10971"
"GO:0006357~regulation of transcription by RNA polymerase II",0.00350877192982456,2.38975038964096,2.13309566250743,0.0574906866845894,0.157768410271465,"1112, 1488, 1845, 22887, 6601, 6721"
"R-HSA-913531~Interferon Signaling",0.00319488817891374,2.16866748951959,2.12930011862396,0.377118028093472,0.405201285504688,"81603"
"GO:1990837~sequence-specific double-stranded DNA binding",0.00334448160535117,2.18624622912406,2.11052322163433,0.2446500237098,0.297308651807765,"22887, 6721"
"KW-0524~Neurogenesis",0.00311526479750779,2.10752635849979,2.07035755478662,0.385518026711698,0.413737764204172,"6601"
"R-HSA-71387~Metabolism of carbohydrates",0.00305810397553517,2.06387161928217,2.02824858757062,0.391745832503338,0.419925662435771,"3423"
"R-HSA-9006931~Signaling by Nuclear Receptors",0.00303951367781155,2.04982785372729,2.01459034792368,0.393808133242531,0.421143050726425,"208"
"GO:0003700~DNA-binding transcription factor activity",0.00319488817891374,2.07987110842067,2.01120448179272,0.262119963463084,0.315741542076342,"1112, 22887"
"KW-0805~Transcription regulation",0.00332363938512671,2.33687013960974,2.00951581304226,0.038777705479716,0.137124360831163,"1112, 1488, 22887, 51322, 55082, 6601, 6721, 9987"
"KW-0560~Oxidoreductase",0.00318471337579618,2.07272987850177,2.00446677833613,0.263369460871806,0.316401636522373,"1488, 2746"
"KW-0744~Spermatogenesis",0.003003003003003,2.02194302050918,1.98781838316722,0.397912413050374,0.425032177982126,"22887"
"WP3932:Focal adhesion PI3K Akt mTOR signaling",0.00298507462686567,2.00840583493498,1.97469746974697,0.399954435257365,0.426711950292189,"208"
"R-HSA-1852241~Organelle biogenesis and maintenance",0.00297619047619048,2.00165350687622,1.96820175438596,0.400972926340407,0.427297057495229,"2746"
"R-HSA-9006925~Intracellular signaling by second messengers",0.0029585798816568,1.98832453154837,1.95533769063181,0.403004881852945,0.428457821759447,"208"
"KW-0508~mRNA splicing",0.0029585798816568,1.98832453154837,1.95533769063181,0.403004881852945,0.428457821759447,"55082"
"KW-0804~Transcription",0.00323232323232323,2.2629381384217,1.95374149659864,0.0447824569672022,0.140855548038709,"1112, 1488, 22887, 51322, 55082, 6601, 6721, 9987"
"GO:0006974~DNA damage response",0.00292397660818713,1.96218524857388,1.93010752688172,0.407048760973061,0.43225154640714,"51322"
"GO:0043065~positive regulation of apoptotic process",0.00291545189504373,1.95575617554932,1.92390139335477,0.408055572955972,0.432403456826384,"10276"
"KW-0391~Immunity",0.00303030303030303,1.96369336344417,1.90249072602014,0.283370919954521,0.335396049789922,"5763, 81603"
"R-HSA-446203~Asparagine N-linked glycosylation",0.00288184438040346,1.9304514800982,1.8994708994709,0.41206626915962,0.436051500193358,"8774"
"GO:0000122~negative regulation of transcription by RNA polymerase II",0.00305498981670061,1.97704978228638,1.88550420168067,0.211537188453685,0.275814088633998,"1488, 6601, 6721"
"R-HSA-388396~GPCR downstream signalling",0.00298953662182362,1.93500398433037,1.87565308254963,0.288995029614173,0.340035920569946,"10276, 208"
"KW-0653~Protein transport",0.00298507462686567,1.93186668617746,1.87271778821075,0.289619779798086,0.340127454705704,"8774, 9522"
"R-HSA-212165~Epigenetic regulation of gene expression",0.00282485875706215,1.88769729148996,1.85817805383023,0.419021668748243,0.442896159176922,"6601"
"GO:0016787~hydrolase activity",0.0028169014084507,1.8817428346653,1.85242518059856,0.420008760594575,0.443423883136433,"3423"
"WP4172:PI3K Akt signaling",0.00269541778975741,1.79113225171499,1.76499508357915,0.435582802518724,0.459332676901995,"208"
"KW-0131~Cell cycle",0.00280112044817927,1.80284538517246,1.75207418252806,0.317051423717528,0.364327792261096,"1112, 23637"
"R-HSA-1640170~Cell Cycle",0.00278940027894003,1.79467502511896,1.7444120505345,0.318916016614491,0.3655670354383,"10971, 208"
"GO:0044877~protein-containing complex binding",0.0026525198938992,1.7593781487879,1.73429951690821,0.44131787725778,0.464841194006167,"1488"
"KW-0945~Host-virus interaction",0.00277392510402219,1.78387490746112,1.73429951690821,0.321400663483778,0.367951137414048,"1488, 9218"
"R-HSA-168256~Immune System",0.00283553875236295,1.88056969975889,1.71852561033988,0.129621526287591,0.217423283130601,"1845, 208, 81603, 9218, 9522, 9987"
"R-HSA-372790~Signaling by GPCR",0.00268817204301075,1.72408350426267,1.6783543712015,0.335650507351898,0.377252228790674,"10276, 208"
"KW-0010~Activator",0.00267379679144385,1.7140774417881,1.66899116689912,0.338121608845824,0.377252228790674,"6721, 9987"
"R-HSA-168249~Innate Immune System",0.0027124773960217,1.73702516641879,1.6682156133829,0.267259908838254,0.319656917281543,"1845, 9218, 9522"
"GO:0106310~protein serine kinase activity",0.00253164556962025,1.67034140971001,1.64830119375574,0.458186100364964,0.4814926765685,"208"
"WP5420:ADHD and autism ASD pathways",0.00248138957816377,1.63354819946625,1.61275831087152,0.465523573683714,0.488638485540988,"208"
"GO:0004674~protein serine/threonine kinase activity",0.00246305418719212,1.62015735395889,1.59982174688057,0.468250207922196,0.490933608998011,"208"
"GO:0005524~ATP binding",0.00262123197903014,1.68310169445868,1.59875306167891,0.238321959350931,0.292354468353571,"10730, 1615, 208, 2746"
"GO:0005102~signaling receptor binding",0.0024390243902439,1.60263420044449,1.58289241622575,0.471864746186201,0.494153288344766,"1857"
"R-HSA-556833~Metabolism of lipids",0.00253807106598985,1.61984485579168,1.58080140907089,0.362692559472206,0.394947461657578,"6721, 9218"
"GO:0005525~GTP binding",0.00240384615384615,1.57703539267297,1.55815972222222,0.477241919957342,0.499209327090016,"2746"
"KW-0833~Ubl conjugation pathway",0.00247831474597274,1.57849478550989,1.54209621993127,0.374261311064285,0.402607729890456,"64795, 81603"
"KW-0723~Serine/threonine-protein kinase",0.00236406619385343,1.54816525434089,1.53026427962489,0.483448206642146,0.505120022801967,"208"
"KW-0507~mRNA processing",0.00234741784037559,1.536107104998,1.51861252115059,0.486086116917167,0.507293088722967,"55082"
"GO:0008285~negative regulation of cell population proliferation",0.00232558139534884,1.52031304221387,1.50335008375209,0.489583018127225,0.510356609492715,"1488"
"KW-0221~Differentiation",0.00238663484486874,1.51522313193353,1.48285832300702,0.392970953265414,0.420742752082758,"1488, 22887"
"GO:0000981~DNA-binding transcription factor activity, RNA polymerase II-specific",0.0023696682464455,1.49864745010492,1.45226537216828,0.34160405154455,0.377252228790674,"1112, 22887, 6721"
"GO:0016887~ATP hydrolysis activity",0.00225225225225225,1.46746722756655,1.45226537216828,0.501641397734564,0.521730012060319,"10730"
"KW-0399~Innate immunity",0.00225225225225225,1.46746722756655,1.45226537216828,0.501641397734564,0.521730012060319,"81603"
"R-HSA-212436~Generic Transcription Pathway",0.00233281493001555,1.47313314645386,1.42914012738854,0.350953068125395,0.384213282407246,"10971, 208, 6601"
"GO:0007165~signal transduction",0.00226928895612708,1.42920308206036,1.38931888544892,0.367763707038377,0.398447210605345,"10276, 10971, 208"
"WP3888:VEGFA VEGFR2 signaling",0.00215982721382289,1.4012552162384,1.38824439288476,0.517565352889082,0.536528970058559,"2746"
"GO:0016567~protein ubiquitination",0.0021505376344086,1.39462446144447,1.38183217859892,0.519212567761875,0.536528970058559,"81603"
"R-HSA-162582~Signal Transduction",0.00226757369614512,1.45414543906353,1.37075219549446,0.268089071902199,0.320227288251115,"10276, 10971, 1488, 1845, 1857, 208"
"GO:0005515~protein binding",0.00228243263142394,7.0502430107139,1.36585665193913,0.000535007322664288,0.0292298017183013,"10276, 10730, 10971, 1112, 1488, 1615, 1845, 1857, 203547, 208, 22887, 23637, 2746, 3423, 51322, 54994, 55082, 57148, 57606, 6152, 6165, 6191, 64397, 64795, 6601, 6721, 81603, 8774, 9218, 9522, 9987"
"R-HSA-9012999~RHO GTPase cycle",0.00205761316872428,1.32854933051029,1.31791483113069,0.536182340998815,0.553223323459617,"10276"
"R-HSA-73857~RNA Polymerase II Transcription",0.0021291696238467,1.33253475847275,1.30166787527194,0.408143196872429,0.432403456826384,"10971, 208, 6601"
"hsa05022_Pathways_of_neurodegeneration",0.00194931773879142,1.25206517610243,1.24393624393624,0.557148986768328,0.57420456799593,"1857"
"GO:0015031~protein transport",0.00193050193050193,1.23883597516527,1.23113854595336,0.560929511899594,0.577446122669004,"9522"
"GO:0001228~DNA-binding transcription activator activity, RNA polymerase II-specific",0.00190839694656489,1.22331659577799,1.21612466124661,0.565424843365093,0.581415364953473,"22887"
"GO:0007283~spermatogenesis",0.00183823529411765,1.17421749718228,1.16861979166667,0.580089260837473,0.595148011400974,"22887"
"KW-0238~DNA-binding",0.00192215281114849,1.18964318146261,1.16634178037687,0.4532224595288,0.476827795962591,"1112, 22887, 6721, 9987"
"KW-9996~Developmental protein",0.00188857412653447,1.17498685454028,1.16407263294423,0.518452923570365,0.536528970058559,"1857, 208"
"KW-0217~Developmental protein",0.00188857412653447,1.17498685454028,1.16407263294423,0.518452923570365,0.536528970058559,"1857, 208"
"R-HSA-74160~Gene expression (Transcription)",0.00183823529411765,1.13275992106063,1.12047440699126,0.5080259008452,0.52776633584947,"10971, 208, 6601"
"GO:0045087~innate immune response",0.00173310225303293,1.10109669574912,1.09785932721713,0.603242659032529,0.616813922452834,"81603"
"KW-0645~Protease",0.00172711571675302,1.09694800820696,1.09384521633151,0.604605375788441,0.617512681563699,"10730"
"R-HSA-69278~Cell Cycle, Mitotic",0.00170940170940171,1.08467402589646,1.08197709463532,0.608666350146321,0.620962640048267,"208"
"GO:0046872~metal ion binding",0.0017531556802244,1.0701127880933,1.05937204910293,0.519411984215107,0.536528970058559,"10730, 208, 64397, 64795, 81603"
"GO:0006508~proteolysis",0.00164203612479475,1.03820756610044,1.0369728480647,0.624509558345461,0.636411646340834,"10730"
"KW-0053~Apoptosis",0.00163398692810458,1.03266294274824,1.0316091954023,0.626445677115903,0.637669787792112,"208"
"GO:0000978~RNA polymerase II cis-regulatory region sequence-specific DNA binding",0.00167644593461861,1.03182021375018,1.02983362019507,0.586255952173108,0.600796686048879,"22887, 6721"
"GO:0042802~identical protein binding",0.00167224080267559,1.01936574449293,1.01757369614512,0.575412320188173,0.591016722091581,"10971, 1488, 81603"
"KW-0378~Hydrolase",0.00163844893500819,0.996329429538877,0.996668517490283,0.590047906420151,0.604001742044952,"10730, 1845, 3423"
"KW-0808~Transferase",0.00146555935515388,0.878741305857124,0.889935547843332,0.669279191526422,0.680508708162771,"208, 64795, 81603"
"KW-0813~Transport",0.00143884892086331,0.860612528438648,0.873479318734793,0.682079474141557,0.692748873737068,"208, 8774, 9522"
"GO:0030154~cell differentiation",0.0013531799729364,0.841277141188515,0.846298915605846,0.700093193009192,0.710250795139905,"22887"
"GO:0004930~G protein-coupled receptor activity",0.00134770889487871,0.837585314047288,0.842723004694836,0.701650126125058,0.711036749885928,"23637"
"GO:0008270~zinc ion binding",0.001388246182323,0.826295053229872,0.842327545753167,0.706638256373586,0.714498526188642,"64397, 64795, 81603"
"GO:0003677~DNA binding",0.00135777325186694,0.818636303404683,0.829865926953306,0.705508142903407,0.714150224832068,"6721, 9987"
"GO:0005509~calcium ion binding",0.00131926121372032,0.818411532420876,0.82415059687787,0.709822307449614,0.716632796100311,"3423"
"R-HSA-382551~Transport of small molecules",0.00131752305665349,0.817241229450169,0.823016964695094,0.710325796794698,0.716632796100311,"10730"
"KW-0418~Kinase",0.00130039011703511,0.80571309397419,0.811849841700588,0.715314322523346,0.720865542321199,"208"
"KW-0443~Lipid metabolism",0.00128040973111396,0.792286171455144,0.79884290164664,0.721190652560196,0.725982617029034,"6721"
"R-HSA-597592~Post-translational protein modification",0.00128783000643915,0.772149721445762,0.786246167323697,0.734107123346806,0.738167450356467,"51322, 8774"
"R-HSA-1280218~Adaptive Immune System",0.00123152709359606,0.759514432745921,0.767094017094017,0.735831994075565,0.739084290181977,"208"
"hsa01100_Metabolic_pathways",0.0012531328320802,0.749128648038068,0.764643237486688,0.748525085151968,0.751003645036577,"2746, 3423"
"KW-0807~Transducer",0.0011001100110011,0.671952904146587,0.682250095020905,0.776988291810689,0.778701606676865,"23637"
"GO:0006355~regulation of DNA-templated transcription",0.00104493207941484,0.635422392238559,0.646846846846847,0.794982736667958,0.79585826831627,"1112"
"KW-0675~Receptor",0.000580383052814858,0.333258952615015,0.353834023260398,0.948030457324863,0.948030457324863,"23637"
